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 Inflammation is a component of the innate immune response. However, severe or 
prolonged inflammation can be detrimental. Dietary n-3 fatty acid supplementation has proven 
clinical benefits in chronic inflammatory diseases, most likely due to reduced synthesis of 
inflammatory mediators and inhibition of lymphocyte proliferation and function. The purposes of 
this study were to characterize alterations in inflammatory mediator production, and lymphocyte 
proliferation, in dogs fed a diet consisting of 0.65% n-3 fatty acids (DMB) with an  n-6:n-3 fatty 
acid ratio of 3.4:1. Fifteen dogs were randomly assigned to one of three dietary groups for twelve 
weeks. Group Sunflower oil received a basal diet supplemented with 12.4g of sunflower oil/day. 
Groups Fish oil and Fish oil +E each received the same basal diet supplemented with 0.6g of 
sunflower oil and 7g of menhaden fish oil. Group Fish oil + E also received 0.18g of vitamin E. 
IL-1, IL-6, TNF-α, PGE2, and PAF were evaluated both in mononuclear cell culture, and in serum 
after in vivo stimulation with lipopolysaccharide. Lymphocyte proliferation was evaluated by 
incorporation of tritiated thymidine as well as sequential halving of a fluorochrome dye, CFSE, 
using flow cytometry. Potential adverse effects of dietary n-3 fatty acid supplementation were 
assessed through serum vitamin E concentrations, plasma lipid peroxidation, platelet aggregation, 
and standard hematologic and serum biochemical parameters. Serum levels of IL-6 and PGE2 as 
well as mononuclear cell culture levels of PGE2 were significantly higher among dogs of Group 
Sunflower oil compared to dogs in Groups Fish oil or Fish oil + E. Lymphocyte proliferation as 
evaluated by flow cytometry was significantly reduced in Group Fish oil at 12 weeks compared to 
Groups Sunflower oil and Fish oil + E. There was no significant diet effect on platelet 
aggregation, lipid peroxidation, or hematologic and biochemical parameters, with the exception of 
decreased triglycerides in Group Fish oil. These data demonstrate that a significant degree of 
immunomodulation is possible with a safe dietary intake and ratio of n-3 fatty acids. Future 
studies should focus on the clinical role of dietary n-3 fatty acid supplementation for the treatment 
of inflammatory diseases and hyperlipidemia.  
CHAPTER I: BACKGROUIND and LITERATURE REVIEW 
 
Immunity 
 Immunity is defined as the status or quality of being resistant to an infectious disease 
(Hensyl, 1990). The immune system of humans and animals is divided by function into the innate 
or natural immunity and acquired or adaptive immunity. Innate immunity is the first line of 
defense and is present before exposure to potential pathogens. This type of immunity consists of 
anatomic barriers such as intact skin and mucosal membranes that prevent entry of pathogens into 
the host. If entry is gained, granulocytes (neutrophils, eosinophils, basophils) and 
monocytes/macrophages can directly destroy pathogens by extracellular release of lysosomal 
enzymes and oxygen-derived free radicals, or through engulfment and subsequent nonspecific 
killing accomplished largely by oxygen-dependent mechanisms (Collins, 1999). Plasma proteins 
like complement or toxic proteins released from natural killer (NK) cells also play a role in 
destruction, by the innate immune system, of many pathogens (Abbas et al., 2000) (Calder, 2001).  
 Acquired immunity involves recognition of specific antigens or peptide components of 
invading pathogens. Recognition is accomplished either by antigen-specific antibodies produced 
by B-lymphocytes, termed the humoral response, or by receptors on the surface of T-lymphocytes, 
called the cell-mediated response. T-lymphocytes are able to recognize foreign peptides only when 
they are presented by other host cells in conjunction with proteins termed major histocompatibility 
complex (MHC). The MHC class I complex is present on the surface of all nucleated host cells. It 
is responsible for presenting peptides that originate from intracellular pathogens, like viruses and 
certain bacteria (Sharon, 1998). MHC class I is specifically recognized by cytotoxic T-
lymphocytes that express the CD8 receptor; CD8+ T-lymphocytes subsequently destroy the 
infected host cell and prevent further propagation of the pathogen. The MHC class II complex is 
only found on antigen-presenting cells such as macrophages, dendritic cells, and B-lymphocytes. 
The peptides presented by this complex are derived from extracellular pathogens that have been 
engulfed or endocytosed by antigen-presenting cells, and are recognized by helper T-lymphocytes 
expressing the CD4 receptor. Recognition of foreign antigen in the context of MHC class II 
stimulates CD4+ T-lymphocytes to produce chemical messengers called cytokines, which activate 
or inhibit different cell types, depending on the type of pathogen (bacteria, viruses, fungi, or 
helminthic parasites) (Sharon, 1998; Abbas et al., 2000) . CD4+ helper T-lymphocytes are 
categorized into two subtypes based on their cytokine production. Type 1 helper (Th1) cells 
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secrete interferon (IFN)-γ and interleukin (IL)-2 which facilitate cell-mediated immunity by 
activating macrophages, cytotoxic T-lymphocytes, and NK cells. Type 2 helper (Th2) cells secrete 
IL-4 and IL-10 which promote B-lymphocytes to produce antibodies. Th2 cells also secrete IL-5 
which is an important eosinophil-activating factor.  
 Communication within the acquired immune system and between the innate and acquired 
immune systems is accomplished through binding adhesion molecules of adjacent cells and by 
production and release of chemical messengers (Calder, 2001). The most important of these 
chemical messengers include synthesized polypeptides called cytokines, and polyunsaturated fatty 
acid metabolites called eicosanoids. There are a multitude of cytokines, many of which have 
multiple functions. However, a few of the more important cytokines have been categorized based 
on their major function(s) or target cell (Collins, 1999). The cytokines most important to the 
acquired immune response regulate lymphocyte and macrophage activation, proliferation, 
differentiation and inhibition. These cytokines include IL-2, IL-4, IL-10, IL-12, transforming 
growth factor (TGF)-β, and interferon (IFN)-γ. The cytokines most involved in natural immunity 
are tumor necrosis factor (TNF)-α, IL-1, and IL-6. TNF-α, IL-1, and IL-6 are synthesized and 
released by activated macrophages and promote neutrophil- and macrophage-mediated killing of 
bacteria and increase expression of adhesion molecules on neutrophils and endothelial cells. IL-1 
receptor antagonists have also been shown to inhibit the production of pro-inflammatory 
eicosanoids LTB4 (Conti et al., 1993) and PGE2 (Arend et al., 1990). TNF-α, IL-1, and IL-6 
stimulate T- and B-lymphocyte proliferation and upregulate MHC, and are therefore an important 
link between natural and acquired immunity (Calder, 2001). Macrophage secretion of IL-1 also 
stimulates T-lymphocyte synthesis of IL-2. IL-2, first described as a T-cell growth factor (Morgan 
et al., 1976), is an important autocrine and paracrine cytokine that promotes the proliferation of T-
lymphocytes, B-lymphocytes, and NK cells.  
 Cytokine receptors consist of one or more transmembrane proteins whose extracellular 
portions bind cytokines and whose cytoplasmic portions initiate intracellular signaling pathways 
(Abbas et al., 2000). Activation of these pathways can result in cell proliferation and synthesis of 
other cytokines, or inhibition of cell activity. Many of the cytokine receptors on the surface of 
lymphocytes are Type I receptors, including receptors for IL-2, IL-4, IL-6, and IL-12. Type I 
receptors typically bind cytokines that fold into four α-helical strands. Type II cytokine receptors 




 Inflammation is defined as ‘a pathologic process consisting of a dynamic complex of 
cytologic and histologic reactions that occur in the affected blood vessels and adjacent tissues in 
response to an injury or abnormal stimulation caused by physical, chemical, or biological agent’ 
(Hensyl, 1990). The “cardinal signs” of inflammation are rubor, redness; calor, heat; tumor, 
swelling; dolor, pain; and functio laesa, loss of function. These signs occur as a result of localized 
increased blood flow, increased vascular permeability which allows complement, antibodies, and 
cytokines to leave the blood stream, and increased movement of circulating leukocytes into the 
affected tissue (Collins, 1999). Although inflammation is part of the normal, innate defense 
against pathogens, it can be harmful. Animals and humans can develop an excessive inflammatory 
reaction after an inappropriate immune response to benign environmental antigens, leading to food 
allergies, asthma, and atopy. In other diseases such as rheumatoid arthritis, systemic lupus 
erythematous and Crohn’s disease, inflammatory reactions are directed at ‘self’ antigens rather 
than foreign pathogens, and often cause irrepairable tissue damage. Lastly, the immune-mediated 
inflammatory response to some intracellular bacterial agents and fungi is so intense that it actually 
causes more host damage than the pathogen, as with Mycobacterium tuberculosis infections. 
Furthermore, chronic, progressive inflammation can be locally destructive to certain tissues as 
well as detrimental to the body as a whole. Pro-inflammatory cytokines such as TNF-α have been 
identified as mediators of anorexia, weight loss and anemia associated with chronic infectious 
diseases (Darling et al., 1990; Argiles et al., 1997). Many cytokines, especially TNF-α and IL-6, 
have also been implicated in the development of cachexia in people and animals with cancer 
(Strassmann and Kambayashi, 1995; Tisdale, 1997; Wigmore et al., 1997).  
Fatty Acid Nomenclature, Classification and Dietary Sources 
 Fatty acids are carboxylic acids varying from 2 to 22 carbons in length. The final carbon, 
opposite the carboxyl group end, is called the “omega” carbon, and is designated by either the 
letter “ω” or “n”. Nomenclature for fatty acids is typically based on the chain length, the number 
of double bonds within the carbon chain, and the location of the first double bond with respect to 
the omega carbon (Reinhart, 1996). For example, the polyunsaturated n-3 fatty acid α-linolenic 
acid is a carboxylic acid consisting of an 18-carbon chain containing 3 double bonds, the first of 
which is between the 3rd and 4th carbon molecules as counted from the omega. It is designated 
18:3n-3 or C18:3n-3 (Figure 1.1). In the same fashion, the saturated fatty acid palmitic acid is 




          CH3 
COOH 
Figure 1.1 α-linolenic acid (18:3n-3). COOH is the carboxyl group on the opposite end from the 
omega carbon, CH3. Double bonds are represented by parallel lines. 
 
 
 Animals and humans cannot insert the first double bond in a fatty acid at the third or sixth 
carbon, nor can they convert one type of fatty acid into another. Therefore, certain essential n-3 
and n-6 fatty acids must be provided in the diet (Reinhart, 1996; Calder, 1997; Kelley, 2001). 
Linoleic acid is the only fatty acid so far proven to be essential in the canine diet, although dogs 
may have other essential fatty acid requirements (Reinhart, 1996). Animals and humans are 
capable of elongation and desaturation of fatty acids towards the carboxyl end of the molecules. 
The n-6 fatty acid linoleic acid (18:2n-6), found in high concentrations within sunflower, 
safflower, and corn oils, can be desaturated and elongated to produce arachidonic acid (AA; 
20:4n-6). Likewise, the n-3 fatty acid α-linolenic acid (18:3n-3) found in flax seed oil can be 
desaturated and elongated to form eicosapentanoic acid (EPA; 20:5n-3).  
 Precursor fatty acids such as linoleic and α-linolenic acids compete for the same desaturase 
enzymes. Therefore, the dietary proportions of n-6 and n-3 fatty acids directly affect the quantity 
and proportions of AA and EPA that are produced and incorporated into cell membranes. Many 
marine plants, especially unicellular algae, elongate and desaturate α-linolenic acid to yield the 
long chain n-3 fatty acids EPA and docosahexaenoic acid (DHA; 22:6n-3). The transfer of these n-
3 fatty acids through the food chain is responsible for their abundance in many fish and marine 
oils (Calder, 1997). Not surprisingly, the consumption of large quantities of marine products was 
related to higher plasma EPA concentrations in Greenland Inuit Eskimos when compared to age- 
and sex-matched Danes (Dyerberg et al., 1975). 
Eicosanoid and PAF Synthesis and Their Role in Inflammation 
 Whether derived directly from dietary sources or converted from essential fatty acids like 
linoleic acid, AA is esterified into leukocyte and other cell membrane phospholipids, particularly 
in the carbon 2 position of phosphatidylcholine, phosphatidylinositol, and 
phosphatidylethanolamine (Collins, 1999; Bochsler and Slauson, 2002). When appropriate 
leukocyte cell membrane receptors bind extracellular ligands such as cytokines, growth factors, or 
chemotactic peptides, cytosolic phospholipases are indirectly activated. These phospholipases, 
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principally phospholipase A2 (PLA2), cleave AA from its esterified position within the membrane 
phospholipids.This also occurs at intracellular membranes such as endoplasmic reticulum and the 
nuclear membrane (Evans et al., 2001). Freed AA is then metabolized by one of two major 
pathways to form numerous compounds called eicosanoids (Figure 1.2). Eicosanoids include 
prostaglandins (PG), thromboxanes (TX), leukotrienes (LT), lipoxins, 
hydroperoxyeicosatetraenoic acids (HPETE), and hydroxyeicosatetraenoic acids (HETE).  
 Metabolism of AA by cyclooxygenase (COX) enzymes gives rise to pro-inflammatory 
eicosanoids, specifically 2-series prostaglandins and thromboxanes. There are two isoforms of 
COX: COX-1 is a constitutive enzyme that is responsible for day-to-day AA metabolism; COX-2 
is transcriptionally regulated and is induced in leukocytes as a result of receptor stimulation during 
inflammation. Hence, COX-2 induction is responsible for increased synthesis of prostaglandins 
during an inflammatory response. The proportion of the different prostaglandins produced varies 
among different leukocytes: macrophages produce large quantities of PGE2 and PGF2a; neutrophils 
produce moderate amounts of PGE2; and, PGD2 is the predominant prostaglandin produced by 
mast cells. PGE2, PGF2a, and PGD2 are in part responsible for the pain, redness, and swelling of 
inflamed tissues. In contrast to its local pro-inflammatory effects, PGE2 also has 
immunosuppressive and/or anti-inflammatory effects (Tilley et al., 2001). PGE2 has been found to 
suppress in vitro T-cell proliferation and IL-2 production (Gordon et al., 1976; Goodwin et al., 
1977; Baker et al., 1981; Rappaport and Dodge, 1982), as well as NK cell cytotoxicity (Brunda et 
al., 1980). The inhibitory effect of PGE2 on lymphocyte proliferation is significantly diminished 
by the addition of the prostaglandin synthetase inhibitor, indomethacin (Goodwin et al., 1978). 
 AA may also be metabolized by an alternative pathway involving one of a family of 
lipoxygenase (LO) enzymes. Of these, the best characterized and most important in the 
inflammatory response is 5-LO. 5-LO must first interact with 5-lipoxygenase-activating protein 
(FLAP), and the active enzyme complex then acts on AA to form 5-hydroperoxyeicosatetraenoic 
acid (5-HPETE) (Collins, 1999; Bochsler and Slauson, 2002). 5-HPETE is the precursor of the 
leukocyte chemotactic agent hydroxyeicosatetraenoic acid (5-HETE) and the 4-series leukotrienes. 
Of major importance is leukotriene B4 (LTB4), which is a potent pro-inflammatory mediator that 
acts as a chemotactic agent for neutrophils. LTB4 also promotes neutrophil chemotaxis and 
increases their adhesiveness to vessel endothelium, lysosomal enzyme release, and oxygen free 
radical generation. LTC4, LTD4, and LTE4 collectively produce intense vasoconstriction, increased 
vascular permeability, and bronchospasm.  
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 Platelet-activating factor (PAF) is actually a family of structurally related bioactive 
mediators derived from PLA2-mediated hydrolysis of choline-containing membrane phospholipids 
(McManus and Pinckard, 2000). The generated lysophosphocholine (lyso-PC) serves as a 
substrate for PAF acetyltransferase, resulting in the formation of PAF (Figure 1.2). PAF was 
originally named because it caused aggregation and secretion of rabbit platelets after its release 
from activated basophils (Benveniste et al., 1972). PAF is now known to have many pro-
inflammatory effects including promotion of vascular permeability, leukocyte adhesion to vascular 
walls, neutrophilic chemotaxis, and production of LTB4 (Collins, 1999). PAF also stimulates pro-
inflammatory activities in target cells including macrophages, eosinophils and vascular endothelial 
cells. 
n-3 Fatty Acid Influence on Eicosanoid and PAF Synthesis 
 The n-3 fatty acids eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) can be 
derived directly from dietary sources such as fish oil, or they can be synthesized in vivo from 
precursor n-3 fatty acids such as α-linolenic acid. EPA and DHA directly inhibit the metabolism 
and biological effects of AA by at least four different mechanisms. First, these long chain n-3 fatty 
acids can be esterified into cell membrane phospholipids, resulting in decreased esterification of 
AA. Second, phospholipase-induced release of AA from the cell membrane is inhibited by EPA 
and DHA (Lands et al., 1973). Third, EPA released from the cell membrane competes with AA as 
substrate for COX and 5-LO enzymes (Reinhart, 1996). Finally, EPA-derived eicosanoids will 
competitively antagonize the action of AA-derived eicosanoids assuming they bind to and initiate 
activity through the same target cell receptors (Calder, 2001). Thus EPA, to some extent DHA, 
and their metabolities, are able to displace AA.  This prevents the synthesis and activity of the pro-
inflammatory AA metabolites, principally the 2-series prostaglandins and the 4-series 
leukotrienes. 
 EPA metabolism by COX and 5-LO enzymes gives rise to 3-series prostaglandins and 
thromboxanes and 5-series leukotrienes, respectively. In contrast to their AA-derived counterparts, 
these EPA-derived eicosanoids are less inflammatory, cause vasodilation, decrease platelet 
aggregation, and are less immunosuppressive (Reinhart, 1996). For example, thromboxane A3 
(TXA3) derived from EPA has attenuated proaggregatory action on human platelets when 
compared to TXA2 (Whitaker et al., 1979). EPA-derived PGE3 appears to be a less potent inhibitor 
of lymphocyte proliferation than PGE2 (Calder et al., 1992). Lastly, leukotriene B5 (LTB5) has 
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Figure 1.2 Eicosanoid and PAF synthesis. Upon stimulation of the cell surface receptor by 
cytokines or other mediators, the mitogen-activated protein (MAP) kinase cascade is activated. 
This leads to the phosphorylation (P = phosphorus) and activation of phospholipase A2 (PLA2) in 
the presence of increased cytosolic calcium (Ca2+). Activated PLA2 cleaves arachidonic acid (AA) 
from membrane phospholipids *(including intracellular membranes) such as phosphatidylcholine. 
Lysophosphocholine (Lyso-PC), also released by PLA2, is acetylated by PAF acetyltransferase to 
form platelet-activating factor (PAF). Cytosolic AA enters one of two enzymatic pathways to form 
numerous proinflammatory eicosanoids. Cyclooxygenase (COX) metabolism of AA leads to the 
formation of 2-series prostaglandins such as PGE2, PGF2α, PGI2 and thromboxane A2 (TXA2). AA 
may alternatively be metabolized by 5-lipoxygenase (5-LO) after this enzyme is activated by 5-
lipoxygenase-activating protein (FLAP), which results in the synthesis of 5-HPETE. 5-HPETE is 
further metabolized into 5-HETE and the 4-series leukotrienes LTA4, LTB4, LTC4, LTD4, and 
LTE4. 
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AA-derived LTB4 (Lee et al., 1988). Therefore, EPA is anti-inflammatory not only due to its 
competitive inhibition of AA metabolism: more importantly, EPA-derived eicosanoids are less 
potent promoters of the inflammatory response and are less immunosuppressive.  
 Unlike other EPA-derived eicosanoids, PGI3 retains the biologic properties of its AA-
derived counterpart PGI2. Both of these prostaglandins inhibit platelet aggregation and relax 
vascular smooth muscle in vitro (Fischer and Weber, 1984) In addition, PGI2 production is 
maintained during periods of EPA dietary supplementation (Fischer and Weber, 1984; von 
Schacky et al., 1985). At least partial inhibition of platelet aggregation would therefore be 
expected in animals and humans supplemented with n-3 fatty acids due to the combination of 
increased PGI3 production, maintained  PGI2 production, and decreased production of  pro-
aggregatory TXA2 (Lee and Austen, 1986). 
  Due to the apparent similarities between eicosanoid metabolism and PAF synthesis, it 
would seem plausible that manipulation of membrane fatty acid composition would also effect the 
production of PAF. EPA is thought to decrease PAF synthesis by replacing the preferred substrate, 
the arachidonate moiety of the choline-containing phospholipid (Prescott, 1992). Direct 
supplementation of EPA to a cultured monocyte-like cell line resulted in a markedly diminished 
capacity to synthesize PAF when compared to cells supplemented with AA (Martin-Chouly et al., 
2000). 
Effects of n-3 Fatty Acid Dietary Supplementation 
 The amount of dietary n-3 fatty acid supplementation or the ratio of n-6:n-3 fatty acids 
needed to maximize benefits without negative effects has not been established. It is likely that the 
absolute intake of n-3 fatty acids and the dietary n-6:n-3 fatty acid ratio are interdependent. When 
diets low in polyunsaturated fatty acid are fed, the influence of the n-6:n-3 fatty acid ratio on 
factors such as lymphocyte proliferation is increased (Jeffery et al., 1997). Another study by the 
same investigators further supports the importance of the dietary n-6:n-3 fatty acid ratio (Jeffery et 
al., 1996). Lymphocyte proliferation, serum cholesterol and triglycerides decreased as the n-6:n-3 
fatty acid ratio decreased and the total amount of fat remained constant in a diet fed to weanling 
male rats. 
 Many authors have investigated the immunologic and hematologic effects of dietary n-3 
fatty acid supplementation in humans and rodents. Several canine studies have also been 
published. Regardless of species most reports have focused on effects on lymphocyte function, 
platelet aggregation, and chemical mediator synthesis, i.e. cytokines, eicosanoids, and PAF. 
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Lymphocyte Function 
 Most reports show that dietary supplementation with polyunsaturated fatty acids (PUFA) 
reduces in vitro proliferation of human (Meydani et al., 1991b; Khalfoun et al., 1996; Terada et al., 
2001) and animal lymphocytes (Baker et al., 1981; Calder et al., 1992; Yaqoob et al., 1994; 
Kuratko, 2000). An early report suggested this suppression was prostaglandin, specifically PGE2, 
dependent (Webb and Jamieson, 1976). This implies that n-6 fatty acids such as linoleic and 
arachidonic acid may cause more suppression than other fatty acids since their metabolism results 
in the production of PGE2. However, most reports demonstrate that n-3 fatty acids are more potent 
suppressors of lymphocyte proliferation (Calder and Newsholme, 1992). This suggests 
polyunsaturated fatty acid (PUFA)-induced suppression occurs through a prostaglandin-
independent mechanism(s), a hypothesis that is supported by the finding that prostaglandin 
synthesis inhibitors have little to no effect on the fatty acid-mediated inhibition (Santoli and 
Zurier, 1989; Calder et al., 1992).    
 Many authors implicate suppressed synthesis and release of IL-2 by T- lymphocytes as an 
important component in the n-3 fatty acid-induced decrease in lymphocyte proliferation (Santoli 
and Zurier, 1989; Calder and Newsholme, 1992; Endres et al., 1993; Jolly et al., 1997; McMurray 
et al., 2000). Jolly and coworkers associated this diminished synthesis of IL-2 with reduced 
production of the intracellular second messengers, diacylglycerol (DAG) and ceramide (Jolly et 
al., 1997). These authors also found that mice supplemented with dietary EPA or DHA had 
reduced IL-2 receptor-α gene transcription within stimulated splenic lymphocytes (Jolly et al., 
1998). Decreased cell membrane expression of the IL-2 receptor α-chain (CD25) has been 
reported on lymphocytes of people with psoriasis and atopic dermatitis receiving supplemental 
EPA and DHA as well (Soyland et al., 1994). In contrast, however, other researchers found no 
reduction in the mitogen-induced lymphocyte expression of activation markers such as CD25 and 
the transferrin receptor CD71 (Khalfoun et al., 1996).  Other mechanisms by which n-3 fatty acids 
could suppress lymphocyte proliferation include inhibition of phospholipase C (PLC)-γ activation 
(Sanderson and Calder, 1998) and reduced expression of interferon (IFN)-γ receptor (Feng et al., 
1999). PLC-γ activation results in downstream events such as induction of IL-2 synthesis and 
expression of the IL-2 receptor, which are important promoters of lymphocyte proliferaion. 
Another important consideration is that as the fatty acid composition of lymphocytes changes, so 
does the fluidity of their cell membranes (Anel et al., 1990). This change in membrane fluidity 
may affect lymphocyte activation and proliferation by altering expression of cell surface receptors.  
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 While manipulation of dietary PUFA concentration does not appear to affect the 
proportions of lymphocyte subtypes, including CD4+ T-lymphocytes, CD8+ T-lymphocytes, and 
CD16+ NK cells (Yaqoob et al., 1994; Jeffery et al., 1997), it does alter cytokine production by 
certain lymphocyte sybsets. Supplementation of n-3 and n-6 fatty acids is reported to reduce the 
production of the Th1-type cytokines IL-2 and IFN-γ, without affecting the Th2-type cytokines IL-
4 and IL-10 (Nishiyama et al., 2000; Wallace et al., 2001).  Other investigators have found that 
dietary n-3 fatty acid supplementation actually enhances the proliferation of IL-4 driven Th2 CD4+ 
lymphocytes, with an associated decrease in proliferation of IL-2 driven Th1 CD4+ lymphocytes 
and CD8+ lymphocytes (Arrington et al., 2001). Regardless, n-3 fatty acids seem to suppress the  
Th-1 type immune response, which would explain some of the benefits observed following the 
administration of fish oil to patients with chronic inflammatory diseases (Wallace et al., 2001). 
  Fewer studies have evaluated lymphocyte proliferation and function among dogs receiving 
diets supplemented with n-3 fatty acids, and these reports vary with respect to methodology and 
conclusions. The only study to evaluate in vitro lymphocyte proliferation showed that 
lymphocytes from young dogs eating a ration consisting of 1.65% fish oil on a dry matter basis 
(DMB), and having an n-6:n-3 fatty acid ratio of 5:1 had an enhanced response to concanavalin A 
(Con A), phytohemagglutinin-P (PHA), and pokeweed mitogen (PWM) (Kearns et al., 1999). 
Older dogs also had an enhanced lymphoproliferative response, although the increase was not 
significant. The discrepancy between these findings and previous reports in other species was 
attributed to maintenance of a normal plasma vitamin E concentration in the dogs throughout the 
dietary trial. In contrast, a study evaluating aged dogs fed a ration containing a mixture of fish and 
corn oils consisting of 4.4% of the diet (DMB) and having an n-6:n-3 fatty acid ratio of 1.4:1, 
showed significant suppression of the T-lymphocyte function based on results of a delayed-type 
hypersensitivity (DTH) skin test (Wander et al., 1997). This n-3 fatty acid-induced effect was 
attributed to increased lipid peroxidation, which has also been implicated as the cause of decreased 
lymphoproliferative responses by other investigators (Meydani et al., 1993). The only study so far 
investigating lymphocyte subtypes found that dogs eating a diet with an n-6:n-3 fatty acid ratio of 
1.4:1 had a decrease in the percentage of CD4+ lymphocytes after a vaccination challenge 
compared to controls (Hall et al., 1999).  
Platelet Aggregation 
 Reports describing the influence of dietary n-3 fatty acid supplementation on platelet 
aggregation are numerous, involve many species, and vary considerably in their results. In most 
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human studies, adenosine diphosphate (ADP)- and collagen-induced aggregation are inhibited 
after consumption of n-3 fatty acids (von Schacky et al., 1985; Kristensen et al., 1989; Freese and 
Mutanen, 1997; Wensing et al., 1999). Two studies reported no n-3 fatty acid-induced change in in 
vitro platelet aggregation in elder human test subjects, but ex vivo platelet aggregation was 
significantly decreased (Salonen et al., 1987; Wensing et al., 1999). The Greenlandic Inuit Eskimo 
diet of whale, seal, and fish products has been implicated as the reason for the impaired platelet 
aggregation (Dyerberg and Bang, 1979) and low incidence of acute myocardial infarction 
observed in this population (Kromann and Green, 1980). Human platelet adhesion to fibrinogen-
coated plates is also reduced by fish oil supplementation (Andrioli et al., 1999).  
 The effects of dietary n-3 fatty acid supplementation on platelet function appear less 
consistent in animal studies. ADP- and collagen-induced aggregation, platelet production of 
TXA2, and aorta production of PGI2 was inhibited when EPA and DHA were supplemented in rats 
(Adan et al., 1999). Cats eating an n-3 fatty acid enriched diet with an n-6:n-3 ratio of 1.3:1 for 16 
weeks had reduced ADP-induced platelet aggregation and prolonged toenail bleeding time 
compared to cats consuming 25:1 and 12:1 ratio diets (Saker et al., 1998). However, no significant 
differences in buccal mucosal bleeding time or collagen-induced platelet aggregation were found 
in another study that compared control cats to cats that received 1.1g of EPA and 0.6g of DHA 
daily for 4 weeks (Bright et al., 1994). Horses had no alteration in ADP-induced platelet 
aggregation after 16 weeks of supplementation with 10% flaxseed oil, a source the of n-3 fatty 
acid α-linolenic acid (Hansen et al., 2002). In contrast, however, a significant reduction in platelet 
accumulations within myocutaneous flaps was demostrated in a porcine model of ischemia and 
reperfusion injury when pigs were supplemented with 7g of n-3 fatty acids daily for 3 weeks 
(Thorwest et al., 2000).  
 Healthy dogs consuming diets with an n-6:n-3 fatty acid ratio of 5:1 for 12 weeks did not 
have significant differences in arachidonic acid-, ADP, or collagen-induced platelet aggregation 
compared to baseline (Boudreaux et al., 1997). Coagulation screening tests and fibrinogen 
activities were also unchanged. Dogs receiving treatment for lymphoma or hemangiosarcoma that 
were concurrently supplemented with menhaden fish oil and arginine at 5.54% of their diet on a 
dry matter basis had no significant changes in platelet aggregation or coagulation times compared 
to control patients with the same malignancies (McNiel et al., 1999). However, dogs fed only 
mackerel fish supplemented with menhaden oil for 10 days had improved patency of small-
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diameter arterial prosthetic grafts and prolonged bleeding times, although their collagen- and 
ADP-induced platelet aggregation was not affected (Casali et al., 1986).  
Chemical Mediator Synthesis 
 Endres and coworkers were the first to show that increased consumption of n-3 fatty acids 
affects cytokine production. Healthy humans were supplemented with 18g of fish oil a day and  
their isolated peripheral blood mononuclear cells were found to produce significantly less TNF 
and IL-1 upon stimulation with bacterial endotoxin (lipopolysaccharide (LPS) from E. coli) 
(Endres et al., 1989). Since then, other human and animal studies have demonstrated similar 
results. Dietary supplementation of EPA and DHA dramatically suppressed LPS-stimulated 
mononuclear cell production of IL-1, IL-6, TNF, and PGE2 in older women and to a lesser extent 
in young women (Meydani et al., 1991b). However, a later study by the same investigators 
showed that granulocyte-macrophage-colony stimulating factor (GM-CSF) was not affected by 
dietary fatty acid manipulation in women or men (Meydani et al., 1993).   
 Similar results have been obtained in studies investigating the effect of dietary n-3 fatty 
acid supplementation in rodents. Activated peritoneal macrophages from mice supplemented with 
fish oil have suppressed production of IL-1, TNF, and PGE2 (Wallace et al., 2000). Furthermore, 
macrophages harvested by bronchoalveolar lavage (BAL) from rats supplemented with fish oil 
have decreased production of LTB4, TXB2 (a stable metabolite of TXA2), and PGE2 (Mancuso et 
al., 1997). The only study investigating the in vivo effects of fish oil on cytokine production found 
that fish oil-supplemented mice injected with intraperitoneal E.coli LPS had lower peak plasma 
concentrations of TNF, IL-1, and IL-6 compared to mice supplemented with safflower oil 
(Sadeghi et al., 1999). Other sources of n-3 fatty acids also appear to effectively reduce the 
synthesis of inflammatory mediators. A 50% reduction in PAF synthesis was demonstrated in 
neutrophils from rats supplemented with α-linolenic acid-rich perilla oil compared to the 
neutrophils from safflower oil supplemented rats (Horii et al., 1991). Dietary n-3 fatty acid-
induced inhibition of inflammatory mediator production has also been observed in cells other than 
immune effector cells. For instance, experimentally-induced hypoxic-ischemic brain tissue of 
young mice previously supplemented with fish oil showed a significant reduction of endogenously 
synthesized PAF and LTB4 (Akisu et al., 2002). 
 Direct supplementation of EPA and DHA to cell culture media inhibits chemical mediator 
synthesis. When added to a murine macrophage cell line, these fatty acids and α-linolenic acid 
suppressed the production of nitric oxide (NO) after activation by LPS (Ohata et al., 1997). In a 
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similar manner, production of PGE2, PGF2α, and IL-1, but not TNF or IL-6, production by a 
human decidual cell line (obtained from fetal membranes) was suppressed when cells were 
cultured with EPA and DHA (Arntzen et al., 1998). PAF production by TNF-stimulated human 
endothelial cells was also diminished when these cells were incubated with EPA and DHA (Mayer 
et al., 2002). 
 Reported production of chemical mediators among dogs supplemented with n-3 fatty acids 
varies between studies. Maintaining young and older dogs on a n-6:n-3 fatty acid ratio diet of 5:1 
for 60 days had no effect on IL-1, IL-6, TNF, or PGE2 production by peritoneal macrophages or 
peripheral blood mononuclear cells (Kearns et al., 1999). However, dogs fed rations with ratios of 
5.3:1 and 10.4:1, where n-3 fatty acids were 3.4 and 1.8 percent of total fatty acids respectively, 
had significantly less LTB4 and significantly more LTB5 synthesized by stimulated neutrophils and 
skin (Vaughn et al., 1994). These investigators also found that PGE2:PGE3 metabolite ratios 
produced from 4-day-old cutaneous wounds increased as the dietary n-6:n-3 fatty acid ratio 
increased (Mooney et al., 1998). In contrast to the findings of  Kearns and coworkers, however, 
fish oil supplementation has reduced PGE2 production by peripheral blood mononuclear cells in 
dogs consuming a diet with an n-6:n-3 ratio of 1.4:1 (Wander et al., 1997). 
Lipid Peroxidation and Vitamin E 
 Lipid peroxidation is an autocatalytic free radical reaction whereby cell membranes rich in 
polyunsaturated fatty acids are attacked by oxidizing radicals. The double bonds within the long 
carbon chains of n-3 fatty acids such as EPA and DHA make cell membranes containing them an 
easy target for superoxide, hydrogen peroxide, hydroxy radicals and other similar compounds 
(Muggli, 1989; Mylonas and Kouretas, 1999). These molecules remove a hydrogen atom from a 
polyunsaturated fatty acid, generating a lipid radical. These lipid radicals then react with 
molecular oxygen to form lipid peroxy radicals, which can attack surrounding polyunsaturated 
fatty acids, and initiate a self-perpetuating chain reaction (Mylonas and Kouretas, 1999). The cell 
membrane damage that results leads to altered immune function, since the cell membrane is 
important in antigen reception, secretion of cytokines and antibodies, and contact cell lysis. Lipid 
peroxidation may also result in increased prostaglandin production by neighboring cells (Knight, 
2000). 
 Lipid peroxidation is a process that normally occurs at low levels in all cells (Hubel et al., 
1989). Most cells and tissues have a multifaceted defense system to keep this potentially 
continuous process under control. Antioxidant defense includes enzymes such as superoxide 
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dismutase, catalase, and glutathione peroxidase; soluble antioxidants like albumin and heme-
binding proteins; nutritional antioxidants such as vitamins C and E; and, metal-containing proteins 
such as cytochromes, ferritin, and lactoferrin (Mylonas and Kouretas, 1999). However, 
consumption of diets high in polyunsaturated fatty acids could overwhelm these mechanisms and 
make additional protection necessary. Additional vitamin E (α-tocopherol) supplementation is 
often recommended in this situation, for two reasons. First, tissue concentrations of vitamin E can 
be increased by simply increasing dietary intake (Meydani et al., 1990; Duthie et al., 1996; Scott 
et al., 2001). Second, its lipid-soluble properties allow it to concentrate within the phospholipid 
membrane, where lipid peroxidation occurs. Vitamin E is the primary defense against lipophilic 
radicals, whereas vitamin C acts against hydrophilic radicals (Dekkers et al., 1996). Although the 
dietary requirements for vitamin E for most animal species are estimated to be between 5 to 50 
IU/KG of diet (Subcommittee on Vitamin Tolerance, 1987), an equation to calculate the dietary 
vitamin E requirement has been developed based on the degree of dietary fatty acid unsaturation 
(Muggli, 1989).  
 Not all forms of vitamin E are equivalent with respect to biologic activity, and vitamin E 
nomenclature is confusing. Naturally occurring α-tocopherol, denoted as d-α-tocopherol or RRR-
α-tocopherol, has the highest potency at 1.49 IU/mg (activity/weight), with its acetate at 1.36 
IU/mg (McDowell, 1989). Vitamin E is usually supplemented in the form of the synthetic dl-α-
tocopheryl acetate, also called all-rac-α-tocopheryl acetate, which has a potency of 1 IU/mg 
(Subcommittee on Vitamin Tolerance, 1987). The isomers β-, γ-, and δ-tocopherol have very little 
biological activity. A source of variability between studies is the method of expression of plasma 
α-tocopherol content. While most authors will simply report plasma α-tocopherol at a 
concentration per unit of plasma, others report the ratio of plasma α-tocopherol concentration to 
the amount of circulating lipids, especially in people with widely varying plasma lipid 
concentrations (Horwitt et al., 1972). Others suggest expressing the α-tocopherol ratio relative to 
the sum of plasma cholesterol and triacylglycerol concentrations or to cholesterol concentration 
alone (Thurnham et al., 1986). However, these ratios may be misleading when evalulating 
experimental populations with diminishing plasma cholesterol concentrations, such as those 
supplemented with high levels of n-3 fatty acids (Meydani et al., 1991a; Hall et al., 2002).  
 The in vivo relationship between n-3 fatty acid intake, vitamin E intake, and lipid 
peroxidation has been studied in people and rodents, but is not fully defined. Both young and older 
women fed fish oil capsules containing 1.68g of EPA, 0.72g of DHA and 6 IU of α-tocopherol for 
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12 weeks had a significant increase in plasma lipid peroxides at 8 weeks (Meydani et al., 1991a). 
Interestingly, while plasma concentration of lipid peroxides approached baseline levels at 12 
weeks, plasma α-tocopherol levels did not change during this study. Likewise, when 
postmenopausal women and adult men were supplemented with fish oil or EPA/DHA plus 
variable quantities of α-tocopherol acetate for 5 to 6 weeks, increased concentrations of lipid 
peroxidation markers were observed. However, these were independent of the level of α-
tocopherol acetate supplementation (Wander et al., 1996; Allard et al., 1997). In the rat, increasing 
quantities of dietary n-3 fatty acids leads to correspondingly increased concentrations of 
thiobarbituric acid reacting substances (TBARS), a product of lipid peroxidation, in the urine, 
heart and liver tissue (L'Abbe et al., 1991). The peripheral blood immune cells from fish oil-fed 
rats that were injected intraperitoneally with a sterile inflammatory agent, glycogen, also had 45% 
less α-tocopherol than lard-fed counterparts (Fritsche and McGuire, 1996). 
 Three studies investigating the role of vitamin E in canine subjects receiving dietary fish 
oil supplementation are summarized in table 1.1. In contrast to reports in other species as well as 
the other canine studies listed in this table, decreased concentrations of the oxidation marker 
malondialdehyde (MDA) and no significant differences in plasma α-topopherol were detected in 
aged dogs in one study (Kearns et al., 1999). This apparent discrepancy may be due to differences 
in the dietary n-6:n-3 fatty acid ratios used in these studies. The only canine study population to 
show an increase in lipid peroxidation also had the only significant decrease in plasma α-
tocopherol (Wander et al., 1997). This reduction on plasma α-tocopherol, a promoter of 
lymphocyte proliferation, may explain why these dogs had depressed cell-mediated immune 
responses based on a delayed-type hypersensitivity test.  
 Dietary supplementation of vitamin E inhibits the suppressive effect of n-3 fatty acid 
supplementation on lymphocyte proliferation (Kramer et al., 1991; Kumar et al., 1992). 
Presumably this effect is due to reduced lipid peroxidation. However, vitamin E has also been 
shown to promote lymphocyte function in experimental conditions where oxidative damage to 
lipids is not present. Proposed mechanisms explaining this promotion of lymphocyte function 
include a vitamin E-related decrease in macrophage production of lymphocyte-inhibiting PGE2 
(Beharka et al., 1997); inhibition of COX activity through the reduction of peroxynitrite 
production is a likely cause for the decrease in PGE2 synthesis (Beharka et al., 2002). Vitamin E 
may also have a more direct enhancing effect on T-cell function, mediated through increased T-
cell production of IL-2 (Meydani et al., 1990; Adolfsson et al., 2001). Vitamin E levels in the 
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thymus may also influence T-lymphocyte differentiation: rats fed a high vitamin E diet had higher 
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Hypotheses and Objectives 
Hypotheses of this study were:  
1. A very low dietary n-6:n-3 fatty acid ratio is needed to significantly affect the production 
of inflammatory chemical mediators in the dog 
2. Polyunsaturated fatty acid supplementation-induced inhibition of lymphocyte proliferation 
is significantly effected by the n-6:n-3 fatty acid ratio  
3. Platelet aggregation is unaffected by manipulation of the dietary n-6:n-3 fatty acid ratio in 
the dog. 
4. Polyunsaturated fatty acid supplementation-induced effects on lipid peroxidation and 
lymphocyte proliferation will be suppressed by dietary vitamin E supplementation 
Specific objectives of this study were: 
1. To assess and compare the effects of a moderate and a low n-6:n-3 fatty acid ratio diet on 
the in vitro and in vivo production of IL-1, IL-6, TNF, PGE2, and PAF in the healthy 
canine; 
2. To determine the effect of these diets on in vitro lymphocyte proliferation using two 
methodologies; 
3. To assess the effect of these diets on platelet aggregation; 
4. To determine the influence of high vitamin E intake and lipid peroxidation in dogs 
consuming the low n-6:n-3 fatty acid ratio diet using the parameters listed in objectives 1, 
2 and 3. 
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CHAPTER II: HEMATOLOGICAL AND SERUM BIOCHEMICAL EFFECTS OF 
DIETARY FISH OIL AND VITAMIN E SUPPLEMENTATION IN THE DOG 
 
Introduction 
 The n-3 fatty acids, particularly eicosapentaenoic acid (EPA), have been extensively 
studied with respect to not only their effects on the immune response, but also in their ability to 
influence platelet aggregation. The low incidence of heart disease in Greenlandic Inuit Eskimos 
(Kromann and Green, 1980) has been attributed to impaired platelet aggregation secondary to a 
diet high in n-3 fatty acid-rich marine life. (Dyerberg and Bang, 1979). The effects of n-3 fatty 
acids on platelet aggregation are thought to be largely due to their impact on eicosanoid 
metabolism. The EPA-derived thromboxane A3 (TXA3) has attenuated proaggregatory activity 
compared to thromboxane A2 (TXA2) which is derived from the n-6 fatty acid arachidonic acid 
(AA) (Whitaker et al., 1979). The EPA-derived prostaglandin I3 (PGI3) retains the anti-
aggregatory activity of its AA-derived counterpart, prostaglandin I2 (PGI2) (Fischer and Weber, 
1984). Finally, EPA reduces the production of another proaggregatory lipid mediator, platelet-
activating factor (PAF) (Martin-Chouly et al., 2000). Through these mechanisms and possibly 
others, dietary n-3 fatty acid supplementation appears to have the potential to reduce platelet 
aggregation, thereby reducing the incidence of blood clot formation or thrombosis. However, the 
results of studies investigating this effect in a variety of species have been mixed. While many 
human (Kristensen et al., 1989; Freese and Mutanen, 1997; Wensing et al., 1999) and animal 
(Saker et al., 1998; Adan et al., 1999) studies have found diminished platelet aggregation in 
subjects supplemented with n-3 fatty acids, other studies have failed to document significant 
changes in platelet function after manipulation of dietary fatty acids (Salonen et al., 1987; Bright 
et al., 1994; Hansen et al., 2002). A diet high in n-3 fatty acids does not appear to significantly 
attenuate in vitro platelet aggregation in healthy dogs (Boudreaux et al., 1989; Vaughn and 
Reinhart, 1996) or canine cancer patients (McNiel et al., 1999). 
 The only other hematologic or serum biochemical effect associated with dietary n-3 fatty 
acid supplementation is decreased serum triglyceride concentrations. Greenlandic Inuit Eskimos 
have lower serum triglycerides as well as reduced platelet aggregation, and this may also 
contribute to their low incidence of atherosclerosis and secondary heart disease (Bang et al., 
1971). Dietary n-3 fatty acid supplementation reduces serum triglycerides in people with primary 
hyperlipoproteinemia (Illingworth et al., 1989; Harris, 1996) as well as normal test subjects 
(Sanders et al., 1989; Harris, 1997), with no apparent effect on total cholesterol. Although dietary 
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n-3 fatty acid supplementation in normal dogs has either had no effect (Hall et al., 1999) or has 
been associated with increased serum triglycerides (Kearns et al., 1999), it is still recommended by 
some authors for the treatment of canine idiopathic hyperlipidemia (Bauer, 1995). Although 
statistically significant increases in the serum concentrations of the hepatocellular-specific enzyme 
alanine transferase (ALT) and cholesterol have been reported in dogs fed high levels of dietary n-3 
fatty acids, concentrations of these analytes were not outside the reference range for healthy dogs 
(Hall et al., 1999). 
 While reduced platelet aggregation could be a beneficial or an adverse side effect of 
dietary n-3 fatty acid supplementation, depending on the circumstances, n-3 fatty acid-induced 
tissue lipid peroxidation can only be detrimental to cells throughout the body. The numerous 
double bonds within long chain n-3 fatty acids makes them prone to attack by oxygen free 
radicals, initiating a self-perpetuating chain reaction that damages host tissue. Lipid peroxidation 
has been implicated in the pathogenesis of a number of diseases (Mylonas and Kouretas, 1999), 
and impairs cell-mediated immune responses as well (Meydani et al., 1993; Wander et al., 1997). 
Vitamin E is probably one of the more important antioxidants in the defense against lipid 
peroxidation because of its lipid solubility and concentration within phospholipid cell membranes. 
Accordingly, increased intake of vitamin E has been suggested when higher levels of 
polyunsaturated fatty acids (PUFA) are consumed (National Research Council, 1985; Muggli, 
1989). Many human and animal studies report increased concentrations of lipid peroxidation 
markers in subjects consuming increased quantities of n-3 fatty acid (L'Abbe et al., 1991; Meydani 
et al., 1991; Wander et al., 1996; Allard et al., 1997; Wander et al., 1997). Evidence of lipid 
peroxidation as well as a significant reduction in plasma α-tocopherol (vitamin E) has been 
documented in dogs consuming rations high in n-3 fatty acids (Wander et al., 1997). 
 The purpose of this study was to determine the effect of an n-3 fatty acid enriched diet with 
a low n-6:n-3 fatty acid ratio, with and without vitamin E supplementation, on platelet 
aggregation, select hematology and serum biochemistry parameters, and lipid peroxidation in 
young, healthy Walkerhound-cross dogs. Dietary induced-changes in each dog was confirmed by 
evaluating serum vitamin E concentrations and the fatty acid proportions of plasma phospholipids. 
Materials and Methods 
Experimental Animals 
 Fifteen healthy Walker Hound-cross dogs were obtained for the study from a colony. The 
study population consisted of eight intact females, six intact males and one castrated male ranging 
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in age from one to four years. Body weights ranged from 46 to 59 pounds. During the study, dogs 
were housed individually in covered outdoor runs and fed once daily. Water was available ad 
libitum. The experimental protocol was approved by the Louisiana State University Institutional 
Animal Care and Use Committee.  
Diet Formulations 
 Previous to the experiment, each dog received approximately 2832 kcal of Laboratory 
Canine Diet 5006 (Lab Diet, Purina Mills, LLC, Gray Summit, MO) per day (800g fed x 3.54 
kcal/g ME). Experimental diets were formulated to meet energy requirements based on the 
equation from the 1974 National Research Council report, ME = 132 x BWkg 0.75 (National 
Research Council, 1985). The experimental population was randomly assigned to three dietary 
treatment groups for the duration of the twelve week study. The first group (Sunflower oil) 
received approximately 500g of Laboratory Canine Diet, top dressed with 12.4g of sunflower oil 
and a 3-5g compressed portion of Hill’s canned canine r/d (Science Diet, Hill’s Pet Nutrition, 
Inc., Topeka, KS). The second group (Fish oil) received 0.6g of sunflower oil, 7g of menhaden 
fish oil (Omega Protein, Inc., Reedville, VA), and a 3-5g compressed portion of Hill’s canned 
canine r/d top dressed on approximately 500g of Laboratory Canine Diet. The third group (Fish 
oil + E) received the same diet as Group B with 0.17g of α-tocopherol acetate injected into the 
compressed portion of r/d canned food. The Laboratory Canine Diet kibble, the sunflower oil, 
and the menhaden fish oil were analyzed by Woodson-Tenent Laboratories (Divison of Eurofins 
Scientific, Inc., Memphis, TN) (Table 2.1), (Appendix I).  
Experimental Design 
 Dogs were fed their assigned diets for 12 weeks. One week previous to the trial and at 
weeks 6 and 12 of the dietary treatment, blood was obtained from each dog for evaluation of 
plasma phospholipid concentrations, serum vitamin E concentrations, platelet aggregation, 
complete blood count, serum biochemical analysis and plasma lipid peroxide concentrations. 
Plasma Phospholipid Analysis 
 Serum was isolated from blood samples on the day of collection and aliquots were frozen 
at -80oC until shipped overnight on dry ice to the Comparative Nutrition Research Laboratory, 
Texas A&M University, College Station, TX. Total lipid extraction was performed using the 
Folch method. Briefly, 9ml of a 2:1 (chloroform: methanol) solvent solution was added to 500µl 
of serum. The sample was shaken for 15 minutes, 2ml of distilled water was added to each tube, 
and the sample was shaken for an additional 10 minutes. The sample tubes were then centrifuged 
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Fish oil + E
Fatty acid (g/day)     
Total Saturated Fat 22.08 15.2 15.7 15.7 
Total MUFA 26.96 19.7 18.4 18.4 
Total PUFA 16.32 17.2 13.4 13.4 
Total Unsat. Fat 43.28 37 31.8 31.8 
Total Fat 65.36 52.2 47.5 47.5 
16:1 n7 1.92 1.2 1.9 1.9 
18:1 n9 24.56 18.2 16.1 16.1 
18:2 n6 15.04 16.4 9.8 9.8 
20:4 n6 0.16 0.1 0.15 0.15 
22:4 n6 <0.1 <0.1 <0.1 <0.1 
18:3 n3 0.8 0.5 0.6 0.6 
18:4 n3 0.16 0.1 0.3 0.3 
20:4 n3 <0.1 <0.1 0.1 0.1 
20:5 n3 <0.1 <0.1 0.75 0.75 
22:5 n3 <0.1 <0.1 0.15 0.15 
22:6 n3 0.08 <0.1 1.0 1.0 
Total n6 9.55 16.6 10.2 10.2 
Total n3 0.65 0.69 2.98 2.98 
n6:n3 ratio 14.69 23.98 3.4 3.4 





for 15 minutes at 1200xg. The bottom layer of each sample was transferred into clean test tubes 
followed by the addition of 5ml of 3:48:47 (chloroform: methanol: water). After an additional 15 
minute vortex and centrifugation, the bottom layer of each sample was again transferred into a 
clean tube and evaporated to dryness under a stream of nitrogen and frozen at -20oC for storage. 
 After the residue of each sample tube was dissolved in 300µl of chloroform, the lipids were 
subfractionated by thin layer chromatography (TLC) on 20 x 20cm silica gel G coated 250µm 
thick glass plates (Fisher Scientific, Pittsburgh, PA). The TLC plates were cleaned in 2:1 
(chloroform: methanol) and heated to 100oC for 40 minutes prior to the fractionation. After the 
plates cooled for 5 minutes, 150µl of each sample was applied in a narrow band about 1cm from 
the bottom of the plate. TLC standard mixture 18-5-A (Nu-Check Prep, Elysian, MN) was applied 
to the last lane of each TLC plate. The plates were developed in a filter paper lined TLC tank 
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equilibrated with 80:20:1 (hexane: diethyl ether: glacial acetic acid) mobile phase until the solvent 
front reached 1cm from the top of the plate. After visualization in an iodine vapor chamber, the 
phospholipid subfraction placement was identified based on established standards and scraped into 
clean Teflon capped test tubes. 
 Recovery of the phospholipids was performed by transmethylation. Briefly, 2ml of 4% 
H2SO4 in methanol was added to each tube followed by 2 minutes of vortexing and 1 hour of 
incubation in a 90oC water bath. After the tubes were allowed to cool to room temperature, 3ml of 
hexane was added, followed by centrifugation for 15 minutes at 1200xg. The top layer containing 
the fatty acids was transferred to clean test tubes and evaporated to dryness under a stream of 
nitrogen. Dried samples were frozen at -20oC for storage until gas chromatography was 
performed. 
 The resultant fatty acid methyl esters of the phospholipid subfractions were resuspended in 
30µl of hexane; one µl of each sample was injected onto an Omegawax 320 fused silica capillary 
column (0.25µm thickness, 30m long, 0.32mm ID) (Supleco, Inc., Bellafonte, PA) using a Hewlett 
Packard Series II 5890 Gas Chromatograph (Hewlett Packard Co, Palo Alto, CA) with a split ratio 
of 50:1. Helium was used as the carrier gas at a flow rate of 1ml/minute, and the final oven 
temperature was 230oC. A flame ionization detector was used and results were generated with a 
Hewlett Packard HP Chemstation software package. Fatty acid methyl ester standards (68-B, 20-
A, Nu-Check Prep, Elysian, MN) were used to identify the individual fatty acids by retention time 
comparisons. 
Serum Vitamin E Analysis 
 Serum was isolated from blood samples on the day of collection and aliquots were frozen 
at -80oC until shipment overnight on dry ice to the Texas Veterinary Medical Diagnostic 
Laboratory (College of Veterinary Medicine, Texas A & M University, College Station, TX). 
Samples were protected from light at all times using aluminum foil and amber glassware. After 
thawing, 500µl of serum and 500µl of ethanol/.01% butylhydroxytoluene (BHT) were combined 
in a culture tube and placed on a rotary extractor for 20 minutes. The samples were extracted by 
adding 1ml of hexane to each tube, followed by rotary extraction for an addition 20 minutes. The 
sample tubes were then centrifuged for 16 minutes at 800xg to separate the hexane layer from the 
polar components. The hexane layer was removed and passed through a hydrophobic Teflon filter 
to remove particulate material and any remaining water.   
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 The concentrations of serum vitamin E were determined by reverse-phase high 
performance liquid chromatography (HPLC) using 95% methanol / 5% deionized water at a flow 
rate of 2.5 ml/minute and a µBondapak C18 column (Waters Corporation, Milford, MA). Eluted 
α-tocopherol and α-tocopherol acetate peaks were identified at an ultraviolet absorbance of 280nm 
by a Waters 484 UV-Vis Detector (Waters Corporation, Milford, MA). The total serum vitamin E 
concentration was determined by summation of the α-tocopherol and α-tocopherol acetate peaks.   
Platelet Aggregation Assay 
 Nine milliliters of whole blood was drawn from the jugular vein of each dog and placed in 
a vacutainer tube containing 1ml of 3.8% sodium citrate. The samples were centrifuged at 150xg 
for 12 minutes. The platelet rich plasma (PRP) was removed and the original sample was 
recentrifuged at 3000xg for 5 minutes to isolate platelet poor plasma (PPP). The platelet 
concentration of the PRP was determined using the Unopette Blood Diluting Pipette System 
(Becton Dickinson and Co, Frankin Lakes, NJ) and a hemacytometer (American Optical Corp, 
Buffalo, NY). The PRP was adjusted to a platelet concentration of approximately 200,000/uL 
using autologous PPP.  
 Platelet aggregation was measured turbidometrically in a dual channel lumi-aggregometer 
(Model 550, Chrono-log Corp, Havertown, PA). Briefly, a cuvet containing a stir bar and 500uL 
of PPP was placed in one of two chambers; the light transmittance through the PPP represents 
100% aggregation. Well-mixed PRP was placed in the second chamber. Collagen at a 
concentration of 20µg/ml, or adenosine 5’-diphosphate (ADP) at a concentration of 20µM, was 
added by forceful infusion to the bottom of the PRP tube to stimulate aggregation. The voltage 
representing the difference in light transmittance between the PRP and PPP was automatically 
determined and applied to a strip chart recorder. The maximal change in light transmittance that 
occurred within 3 minutes was determined using the point of maximal shape change as baseline 
(Boudreaux et al., 1989).  
Hematology and Serum Biochemistry Analysis 
 Calculated red blood cell hematocrit, platelet concentration, and white blood cell 
concentration were obtained from whole blood in EDTA using a standard impedance hematology 
analyzer (Baker System 9110 plus, Biochem Immunosystems Inc, Allentown, PA). Serum 
triglyceride concentrations were obtained using a ‘dry’ chemistry analyzer system, in which 
biochemical reactions occur on film and are then measured optically (Vet Test 8008, Idexx 
Laboratories Inc, Westbrook, MA). All other biochemical analytes were measured using a 
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standard spectrophotometric analyzer (Olympus AU 600, Olympus America Inc, Melville, NY), 
and reagents manufactured by the same company.  
Plasma Lipid Peroxide Analysis 
 Plasma from each dog was isolated from heparinized blood by centrifugation and stored at 
-80oC until time of analysis. The concentration of plasma lipid hydroperoxides was determined 
using a colorimetric, quantitative assay according to the manufacturer’s instructions (Bioxytech 
LPO-560, Oxis International, Inc., Portland, OR). The assay is based on the oxidation of ferrous 
ions to ferric ions by hydroperoxides. The newly-formed ferric ions bind with xylenol orange to 
produce a stable, colored complex that can be measured spectrophotometrically. Briefly, 90µl of 
each plasma sample was pretreated with 10µl of catalase to eliminate H2O2 interference with the 
lipid hydroperoxide measurement. A corresponding blank sample was made to obtain the net 
absorbance for each test sample. Ten µl of reducing agent 20mM tris (2-carboxyethyl) phosphine 
(TCEP) in deionized water was added to each blank sample. Ten µl of deionized water was also 
added to each test sample. After 30 minutes of incubation at room temperature, 900µl of newly 
made working reagent was added to all tubes. The working reagent was prepared the day of each 
assay run and consisted of  1 volume of  color developer (25mM ferrous ammonium sulfate in 
2.5M H2SO4) to 100 volumes of chromogen (125µM xylenol orange in methanol). Following 
incubation for 60 minutes at room temperature, all tubes were centrifuged at 10,000xg for 10 
minutes to remove all flocculated material. After the spectrophotometer was zeroed with deionized 
water, the absorbance of all supernatants was measured at 560nm.  
 The net absorbance was obtained by subtracting the absorbance value of each sample blank 
from the absorbance value of its corresponding sample. The concentration of hydroperoxides in 
each plasma sample was calculated from the net absorbance and the hydroperoxide apparent molar 
extinction coefficient of 4.31x104 M-1 cm-1 using the following equation: 
    [LOOH] = (Net A560/ε) x δ   where: 
[LOOH] = concentration of lipid hydroperoxides in the sample (µM) 
Net A560 = Net absorbance at 560nm 
ε = 0.0431 M-1 cm-1 
δ = dilution factor = 11.2 (1.010ml / 0.090ml) 
Statistical Analysis 
 The effect of group and time on the concentration of plasma fatty acids was evaluated 
using a multivariate model that accounted for the random variance of dog. Fatty acids with the 
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same degree of unsaturation were evaluated together. Statistical significance of the interaction of 
group and time was determined using Wilk’s lambda with p<0.05. Where there was a significant 
interaction of group and time, contrasts were made for each plasma fatty acid using Tukey’s test to 
determine where the difference occurred. An experiment-wide type I error of 0.05 was maintained.  
 All other data were considered continuous and found to follow a normal distribution with 
rejection of the null hypothesis of normality at p<0.05 using the Shapiro-Wilk test. The effect of 
diet and time was evaluated using a mixed effect linear model that accounted for the random 
variance of each dog, and the repeated measurements in each dog. Where there was significant 
interaction of diet and time, least squares means comparisons were made between and within diet 
groups to determine where the significance effects occurred. If the groups behaved differently then 
they were considered to be different. If the groups showed similar significant changes over time, 
then between group comparisons were made at the significant time points. Type I error was 
maintained at 0.05 for all between and within group comparisons. All data were summarized as 
mean +/- SEM. PROC NPAR1WAY (SAS v8.0, SAS Institute, Cary, NC) was used for the 
analysis.  
Results 
 All 15 dogs consumed between 75 and 100% of the amount of food calculated to be 
required to meet individual maintenance energy requirements each day throughout the 12 week 
period of study. All dogs maintained optimal body condition without significant weight loss or 
gain (Appendix II).  
Consumption of the test diets was confirmed by observing the dogs at the time of feeding, 
and by the significant increase in plasma phospholipid n-3 fatty acids (Table 2.2). Previous to the 
study, the plasma fatty acid profile of dogs in each of the three diet groups was not significantly 
different. After eating the experimental diet for 12 weeks, the concentration of plasma saturated 
and polyunsaturated fatty acids (PUFA) still did not differ significantly among dogs in the three 
groups. However, there were significant but inconsistent changes in the total monounsaturated 
fatty acids (MUFA) among the three groups. The total MUFA concentration steadily increased in 
Group Sunflower. Dogs in Group Fish oil +E had increased total plasma MUFA concentrations at 
6 weeks, but these returned close to baseline by 12 weeks. Variable patterns were found in the 
concentrations of the individual MUFAs in both fish oil groups over the course of the experiment, 































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































 As expected, there was a significant increase in total n-3 fatty acids and a decrease in 
total n-6 fatty acids in both groups supplemented with fish oil from week 0 to weeks 6 and 12. 
This fish oil-induced effect was also reflected in the significantly decreased n-6:n-3 fatty acid 
ratios of both groups.  No significant difference in individual or total n-3 or n-6 fatty acids was 
detected between the two groups supplemented with fish oil. Surprisingly, Group Sunflower 
oil also had a significantly decreased n-6:n-3 fatty acid ratio (48.7% reduction), although not to 
the same magnitude as Groups Fish oil and Fish oil + E (75% and 76.4%, respectively). This 
sunflower oil-induced reduction of the n-6:n-3 fatty acid ratio was predominantly the result of 
a significant decline in arachidonic acid (20:4 n-6) combined with a significant elevation in 
eicosapentaenoic acid (20:5 n-3).  
 The combined concentration of serum α-tocopherol and α-tocopherol acetate (serum 
vitamin E) did not differ significantly among the three groups previous to the study (Figure 
2.1), (Appendix III). After consumption of the diets for 6 and 12 weeks, the total 
concentrations of serum vitamin E of Group Fish oil + E significantly increased when 
compared to the week 0 concentration. Comparison between groups also found the serum 
vitamin E concentrations of dogs in Group Fish oil + E at weeks 6 and 12 to be significantly 
higher than those of the Groups Sunflower oil and Fish oil. The serum vitamin E 
concentrations of the latter two groups did not change significantly over the course of the 
study. When vitamin E was expressed as a ratio relative to serum triglyceride, cholesterol, or 
total lipid (triglyceride + cholesterol) concentrations, the differences within and between 
dietary groups were the same with two exceptions. First, the serum vitamin E concentration of 
Group Fish oil + E significantly increased from week 6 to 12 when expressed relative to serum 
triglycerides alone. Secondly, when expressed relative to serum triglyceride and total lipid 
concentrations, Group Fish oil had a significantly increased serum concentration of vitamin E 
from week 0 to week 12. 
 Platelet aggregation in platelet rich plasma as induced by ADP was not significantly 
different within or between dietary groups at any time point (Figure 2.2). Collagen-induced 
platelet aggregation among dogs in Group Fish oil +E was significantly reduced at week 6 
compared to baseline, but rebounded to a value not significantly different than baseline by 
week 12. There was no significant difference between the three dietary groups at any time 
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Figure 2.1 Effect of diet on serum vitamin E. Serum vitamin E levels are expressed as a 
concentration per unit of plasma (A), and as ratios per unit of total lipid (cholesterol + 
triglyceride) (B), triglyceride (C), and cholesterol (D). Data is expressed as means +/- SEM, 
n=5. Significant difference within a group over time is indicated by different symbols (*,†,‡). 
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Figure 2.2 Effect of diet on ADP-induced platelet aggregation. Values are percent light 






                         















Fish oil + E
*
*
  † 
Figure 2.3 Effect of diet on collagen-induced platelet aggregation. Values are percent light 
transmittance (%LT) reported as means +/- SEM, n=5. Significant difference within a group 




 Aside from the serum cholesterol concentration of Group Fish oil + E, none of the 
hematologic or serum biochemical parameters examined were outside the laboratory reference 
interval for any of the three dietary groups at any time point (Table 2.3), (Appendices V, VI, 
VII). The serum cholesterol concentration of Group Fish oil + E was significantly decreased at 
weeks 6 and 12 when compared to baseline. However, there were no significant differences in 
serum cholesterol concentrations between the three dietary groups at weeks 0, 6, or 12. 
Reduced serum triglyceride concentrations were found in Groups Fish oil and Fish oil + E by 
week 12, but only the week 12 triglyceride concentration of Group Fish oil was significantly 
lower when compared to week 0 in this group. Comparison between groups also revealed this 
parameter to be significantly lower than the concentration of serum triglyceride in Group 
Sunflower Group at week 12. Although week 12 serum triglyceride concentration in Group 
Fish oil was within the laboratory reference interval, it was below published reference intervals 
(Wagner et al., 1999).   
 There was no evidence of oxidative damage in any of the dietary groups. Plasma lipid 
hydroperoxide concentrations did not differ significantly from baseline at weeks 6 or 12 for 
any of the three dietary groups, and there was no significant difference between groups at any 
of the three time points (Figure 2.4), (Appendix VIII).  
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Figure 2.4 Effect of diet on plasma lipid hydroperoxide concentrations. Values are 























































   
   
   
   
   
   

























































































































































































































































































































































































































































































































































































































































































































































































































 Dietary supplementation with n-3 fatty acids inhibits platelet aggregation in humans 
and animals (Kristensen et al., 1989; Freese and Mutanen, 1997; Saker et al., 1998; Adan et 
al., 1999). This effect was first described in Greenlandic Eskimos, who consume a 
significantly larger quantity of n-3 fatty acids than other human populations (Dyerberg and 
Bang, 1979). Significant n-3 fatty acid-induced inhibition of platelets was not found in healthy 
dogs fed a ration with an n-6:n-3 fatty acid ratio diet of 5:1 (Boudreaux et al., 1997), or among 
canine cancer patients supplemented with menhaden fish oil and arginine at 5.54% on a dry 
matter basis yielding an n-6:n-3 fatty acid ratio of 0.3:1 (McNiel et al., 1997). A significant 
decrease in collagen-induced platelet aggregation was noted after 6 weeks in 1 of 2 diet groups 
in the current study in which the dietary n-3:n-6 fatty acid ratio was 3.4:1 after addition of  
0.65% n-3 fatty acids on dry matter basis (DMB). However, these values returned close to 
baseline after an additional 6 weeks on the same diet (week 12 of study). This temporary effect 
on collagen-induced platelet aggregation has been documented in other studies (Thorngren and 
Gustafson, 1981; Boudreaux et al., 1997). Since different glycoproteins mediate ADP- and 
collagen-induced platelet aggregation (Peerschke, 2002), a significant reduction of in vitro 
aggregation induced by only one agonist implies that other pro-aggregation mechanisms 
remain in place. Therefore, this temporary reduction of collagen-induced platelet aggregation 
is thought to be of little clinical significance. The results of platelet aggregation analysis in the 
current study confirm that young, healthy dogs consuming a ration with a n-6:n-3 fatty acid 
ratio of 3.4:1(1.65% added oil on dry matter basis) have preserved platelet function.  
 Another potential effect of diets high in polyunsaturated fatty acids such as n-6 or n-3 
fatty acids is increased lipid peroxidation of all cells and tissues (Hall, 1996). The long chain 
polyunsaturated fatty acids that are incorporated into cell membrane phospholipids are easy 
targets for oxygen free radicals, due to their numerous double bonds (Mylonas and Kouretas, 
1999). Evidence of increased lipid peroxidation has been found in both human (Meydani et al., 
1991; Allard et al., 1997) and animal studies (L'Abbe et al., 1991; Wander et al., 1997) in 
which test subjects were supplemented with n-3 fatty acids. Diets enriched with the lipid-
soluble antioxidant vitamin E at levels greater than established requirements have been 
proposed for humans and dogs eating diets high in PUFAs (National Research Council, 1985; 
Muggli, 1989). However, given the variability from study to study, it is difficult to specifically 
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define the vitamin E (α-tocopherol) intake needed to prevent significant lipid peroxidation that 
may be caused by high n-3 fatty acid diets in the dog. A formula has been proposed that 
calculates human vitamin E requirements based on the number of double bonds within dietary 
PUFAs (Muggli, 1989). The National Research Council’s Subcommittee on Dog Nutrition 
recommends an α-tocopherol:PUFA ratio (mg/g) of at least 0.5 be maintained (National 
Research Council, 1985). All three of the experimental diets used in the current study far 
exceeded these recommendations. Therefore, it is not surprising that no significant differences 
in plasma lipid peroxide concentrations were found between any of the dietary groups, even 
though dogs in Group Fish oil + E had significantly higher serum vitamin E concentrations. 
Evidence of significantly increased lipid peroxidation has only been reported once in dogs 
consuming an n-3 fatty acid enriched diet (Table 2.4). This observation may have been related 
to the lower n-6:n-3 fatty acid ratio and the high percentage of PUFA-rich oil within the diet of 




Table 2.4 Dietary comparison of canine studies.  












Kearns et al. 1.65 5:1 Not given 100 
Wander et al. 4.4 1.4:1 42.9 451.6 
Hall et al. 4.4 1.4:1 33.85 1870 
Current Study 1.65 3.4:1 56.05 427 
* Polyunsaturated fatty acid (PUFA) concentration on a dry matter basis (DMB) was 
determined by the sum of 18:2n-6 + 18:3n-6 + 18:3n-3 + 18:4n-3 + 20:2n-6 + 20:3n-6 + 






 The significant decrease in serum cholesterol noted here in Group Fish oil + E, was 
observed among n-3 fatty acid supplemented dogs in one earlier study (Hall et al., 1999). 
Nevertheless, serum cholesterol concentrations as well as all other serum biochemistry and 
hematology parameters assayed here were within the laboratory reference interval, suggesting 
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that this level and duration of n-3 fatty acid supplementation is safe in the dogs. There was a 
significant reduction of serum triglycerides in one of two diet groups supplemented with n-3 
fatty acids (Group Fish oil), in agreement with work in human subjects (Sanders et al., 1989; 
Harris, 1997); this has not been previously reported in the dog. Diets rich in n-3 fatty acids are 
suggested to reduce serum triglycerides by decreasing the production of VLDL particles, 
which typically contain a high concentration of triglycerides. Furthermore, fish oil is a poor 
substrate for enzymes responsible for triglyceride synthesis (Elliott, 2001). Hyperlipidemia is a 
disturbance of lipid transport characterized by significantly high levels of serum triglycerides. 
Clinical signs include vomiting, diarrhea, and potentially seizures. The dietary n-3 fatty acid-
induced decrease in serum triglycerides observed in this study may prove beneficial in dogs 
with hyperlipidemia. 
 The control group in this study was supplemented with sunflower oil to increase the n-
6:n-3 fatty acid ratio to a level more consistent with most standard canine diets. Sunflower oil 
is high in linoleic acid (LA, 18:2 n-6), which is typically desaturated and elongated to 
arachidonic acid (AA, 20:4 n-6) as its principle end-product. The first and probably primary 
rate-limiting step in this pathway is regulated by the enzyme ∆6-desaturase (Cook, 1991; 
Dunbar and Bauer, 2002). Alpha-linolenic (LNA, 18:3 n-3) competes directly for this 
desaturase enzyme plus others, and is eventually metabolized to eicosapentaenoic acid (EPA, 
20:5 n-3) and docosahexaenoic acid (DHA, 22:6 n-3) (Simopoulos, 1991; Dunbar and Bauer, 
2002). The significant decrease in AA with its resultant decrease in the plasma phospholipid n-
6:n-3 fatty acid ratio of Group Sunflower oil in the current study was therefore surprising 
(Table 2.2). EPA and DHA concentrations were also significantly increased, despite 
undetectable dietary intake (Table 2.1), thus suggesting endogenous synthesis of these fatty 
acids. These unexpected findings may be the result of several contributing factors. Early 
reports suggested that LNA is a preferred substrate for ∆6-desaturase compared to LA (Hagve 
and Christophersen, 1984; Cook, 1991). This may have contributed to the increased EPA and 
DHA and the decreased AA concentrations in the plasma phospholipids of the dogs studied 
here. Decreased AA concentrations may also have been related to reduced ∆6-desaturase 
activity. Fasting for at least 12 hours is thought to diminish ∆6-desaturase activity (Inkpen et 
al., 1969; De Gomez Dumm and Brenner, 1975), and the dogs in the current study were fed 
once daily. High dietary LA intake has been associated with depressed desaturase activity as 
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well (Uchiyama et al., 1967) and specifically with the inhibition of ∆6-desaturase (unpublished 
data, J.Bauer). Lastly, there is evidence to suggest that low endogenous levels of AA favor the 
esterification of EPA into phospholipids as opposed to triacylglycerols (Hagve and 
Christophersen, 1984). Therefore, the decreased AA and increased EPA concentrations found 
in the plasma phospholipid fraction of dogs in Group Sunflower oil may have reflected 
changes present only in the lipid fraction that was evaluated, and may not have been 
representative of the entire lipid profile. 
 In summary, this study shows that consumption of a diet consisting of 0.65% n-3 fatty 
acids on a DMB with an n-6:n-3 fatty acid ratio of 3.4:1 did not cause a clinically significant 
or sustained inhibition of platelet aggregation in young adult dogs. Increased lipid peroxidation 
was not apparent in these animals whether or not they received additional dietary vitamin E 
supplementation. The routinely recommended intake of dietary vitamin E may therefore be 
adequate for young dogs with this level of fatty acid consumption. Increased intake of n-3 fatty 
acids decreases serum triglyceride concentrations in the dog, and may have a role in the 
treatment of hyperlipidemia. Finally, the metabolism of dietary n-6 and n-3 fatty acids may be 
much more complex than the simple pathways imply. Further studies are required to fully 
elucidate these mechanisms.  
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CHAPTER III: EFFECTS OF DIETARY FISH OIL AND VITAMIN E 
SUPPLEMENTATION ON CANINE LYMPHOCYTE PROLIFERATION 
 
Introduction 
 Dietary supplementation with fish oil or its main n-3 fatty acid constituents, 
eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), has long been reported to have 
anti-inflammatory and immunosuppressive effects that are potentially beneficial to animals and 
humans with chronic inflammatory diseases. Despite variable rates of n-3 fatty acid 
supplementation and differing n-6:n-3 fatty acid ratios, most human and rodent studies agree that 
diets supplemented with n-3 polyunsaturated fatty acids suppress lymphocyte proliferation and 
function (Meydani et al., 1991; Calder and Newsholme, 1992; Endres et al., 1993; Jeffery et al., 
1997b; Jolly et al., 1997) . Dietary supplementation with n-3 fatty acid appears to be a more potent 
suppressor of lymphocyte proliferation than dietary supplementation with n-6 fatty acids (Calder 
and Newsholme, 1992; Calder, 1998), although prostaglandin E2 (PGE2), an eicosanoid derived 
from the n-6 fatty acid arachidonic acid (AA), is reportedly more immunosuppressive than the 
corresponding n-3 fatty acid-derived prostaglandin E3 (PGE3) (Reinhart, 1996). This suggests a 
prostaglandin-independent mechanism for the observed decrease in lymphocyte proliferation, even 
though many of the immunomodulating effects of n-3 fatty acids are thought to be related to their 
effect on eicosanoid synthesis. 
 Originally designated T-cell growth factor, interleukin (IL)-2 is an important autocrine and 
paracrine cytokine that promotes T-cell, B-cell, and natural killer cell proliferation and 
differentiation (Sharon, 1998). The mechanism behind the effects of fish oil or its n-3 fatty acid 
constituents on lymphocyte proliferation may be related in part to decreased production of IL-2 
(Calder and Newsholme, 1992; Kumar et al., 1992; Endres et al., 1993; Jolly et al., 1997; Terada 
et al., 2001). Reduced expression of the IL-2 receptor on the lymphocyte surface would have an 
equivalent effect (Soyland et al., 1994; Terada et al., 2001). 
 Reduction of lymphocyte proliferation in experimental subjects fed diets supplemented 
with n-3 fatty acids may also be related to the production of lipid peroxides, with subsequent 
oxidative damage of cell membranes (Meydani et al., 1991; Kumar et al., 1992). The numerous 
double bonds within the long carbon chains of n-3 and n-6 fatty acids allow cell membranes 
containing them to become easy targets for oxygen-derived free radicals (Muggli, 1989). While 
reduced lymphocyte function may be desirable in patients with chronic inflammatory diseases, 
widespread oxidative damage of cell membranes would be detrimental. Vitamin E is an important 
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fat-soluble antioxidant capable of protecting unsaturated fatty acids from oxidative damage, and is 
reported to restore diminished lymphocyte proliferation secondary to fish oil supplementation 
(Kramer et al., 1991; Kumar et al., 1992). The promotion of lymphocyte proliferation by vitamin 
E may be due to inhibition of oxidative damage (Kumar et al., 1992), but could also be related to 
decreased PGE2 production or increased IL-2 synthesis (Beharka et al., 1997; Adolfsson et al., 
2001).  
 Few studies have evaluated lymphocyte proliferation and function in dogs eating diets 
supplemented with n-3 fatty acids. Those that exist have varied in methodology, and report 
contrasting conclusions. The only study to assess mitogen-stimulated lymphocyte proliferation 
found an increased mitogenic response in young dogs eating an n-3 fatty acid supplemented diet 
with an n-6:n-3 ratio of 5:1. Older dogs consuming the same diet had no change in their mitogenic 
response (Kearns et al., 1999).  This study also evaluated mononuclear cell production of PGE2, 
serum vitamin E concentration and serum markers of oxidative stress. An increase in one of two 
serum markers of oxidation in the older dogs was the only other significant finding. In contrast, a 
report evaluating aged dogs fed a diet with an even lower n-6:n-3 fatty acid ratio of 1.4:1 
documented significant suppression of the cell-mediated immune response based on results of a 
delayed-type hypersensitivity (DTH) skin test (Wander et al., 1997). These dogs also had evidence 
of increased lipid peroxidation, lower plasma vitamin E concentrations, and decreased 
mononuclear cell PGE2 production when compared to aged dogs receiving a ration with an n-6:n-3 
fatty acid ratio of 31:1. 
 The objective of this study was to determine the effect of feeding a low n-6:n-3 ratio diet 
consisting of 0.65% n-3 fatty acids (DMB) for 12 weeks on lymphocyte activation and 
proliferation in healthy, young dogs, using the standard tritiated thymidine method as well as flow 
cytometry techniques. The effect of dietary vitamin E supplementation on any changes induced by 
the diet was also assessed. A tertiary objective of this study was to evaluate diet-induced changes 
in plasma vitamin E and lipid peroxide concentrations and mononuclear cell production of PGE2, 
and relate these to the results of the lymphoproliferative assays.  
Materials and Methods 
 The in vitro experiments reported in this chapter were conducted using the experimental 
animals and diet formulations already described in Chapter II. The peripheral blood mononuclear 
cells used for the lymphoproliferative studies and PGE2 synthesis analysis were collected at week 
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0 and week 12 of the dietary treatments. Methods and results of serum vitamin E and plasma lipid 
peroxide level determinations were presented in Chapter II. 
Peripheral Blood Mononuclear Cell Isolation 
 Prior to blood collection in each of the 15 dogs, two 50ml conical tubes were filled with 
approximately 20ml of a density gradient of 1.077 (Lymphoprep, Nycomed Pharma As, Oslo, 
Norway) and chilled in an ice bath for 45 minutes. Approximately 15ml of heparinized whole 
blood was slowly overlaid on the gradient in each tube, and centrifuged for 45 minutes at 340xg 
and 15oC. After centrifugation, the mononuclear cell layer between the plasma and gradient was 
removed with negative pressure through a pipet. The viable cell concentration was determined by 
trypan blue exclusion and the mononuclear cell percentage was determined by microscopic 
evaluation of a modified Wright’s stained cytospin-prep slide. Viability was >90% in all samples 
and the cell population was typically 80-90% mononuclear cells. However, up to 30% neutrophils 
were present in a small number of isolates. 
Evaluating Lymphocyte Proliferation using Tritiated Thymidine 
 Lymphocytes were suspended in triplicate in a 96-well U-shaped bottom plate at 2x105 
cells per well in 200µl of complete medium (RMPI with NaHCO3, 25mM HEPES, 2-mercato 
ethanol, and pen strep glutamine) with 10% heat-inactivated autologous serum. 
Phytohemagglutinin-P or Concanavalin A was added to wells at a final concentration of 2µg/ml. 
No mitogens were added to control wells. After incubation at 37oC in humidified air containing 
5% CO2 for 72 hours, 1 µCi of tritiated thymidine in 50µl of complete medium, without 
autologous serum was added to each well and the plates were allowed to incubate for an additional 
4 hours. All plates were then frozen at -20oC until time of harvest. Following defrost, the plates 
were harvested onto glass fiber filters (Tomtec Harvestor, Orange, CT) and incorporation of 
tritiated thymidine was determined by liquid scintillation spectrophotometry (Betaplate liquid 
scintillation counter 1205, LKB Wallac, Turku, Finland). Results were reported as the average 
counts per minute (CPM) of the triplicate wells. The stimulation index (SI) was determined by 
dividing the average CPM of the stimulated population by the average CPM of the unstimulated 
control population. 
Lymphocyte Staining with Intracytoplasmic Fluorochrome   
  Five microliters of 5mM carboxyfluorescein diacetate succinimidyl ester (CFSE) 
(Molecular Probes, Eugene, OR) diluted 1:10 with dimethyl sulphoxide (DMSO) was added to 
9x106 lymphocytes in 1ml of complete medium and incubated in a 37oC water bath for 10 minutes. 
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A separate aliquot of lymphocytes was also incubated without the addition of CFSE (negative 
control). Both aliquots of cells were washed twice, diluted to1x106 lymphocytes/ml with complete 
media plus 10% autologous serum, and transferred to 24-well flat bottom plates at 1ml/well. 
Phytohemagglutinin-P or Concanavalin A was added to wells at a final concentration of 2µg/ml. 
Each population of cells, determined by mitogen and presence or absence of CFSE, was cultured 
in triplicate wells. Plates were incubated at 37oC in humidified air containing 5% CO2 for 
approximately 72 hours. 
Immunophenotyping 
 Following 72 hours of incubation, cells from triplicate wells were combined and 
transferred to large falcon tubes. The cells were then washed with sterile PBS and resuspended 
with 150µl of PBS. Twenty-five microliters from each sample population was transferred into a 
small falcon tube for surface staining. Immunophenotyping was carried out by adding 10µl of 
mouse anti-canine CD4 (IgG1), anti-canine CD8α (IgG2a), or anti-canine CD21 (IgG1) 
monoclonal antibody (Leukocyte Antigen Biology Laboratory, University of California, Davis). 
Following 60 minutes of incubation at 4oC, cells were washed with PBS and 50µl of goat anti-
mouse IgG (H+L) conjugated to Tricolor (TC) fluorochrome (Caltag Laboratories, Burlingame, 
CA) was added to each tube at a 1:100 dilution. In separate tubes also containing 25µl of sample, 
identification of activated lymphocytes was performed by adding 10µl of biotinylated recombinant 
human IL-2 or a negative control, biotinylated soybean trypsin inhibitor (R&D Systems, Inc. 
Minneapolis, MN). Following 60 minutes of incubation at 4oC, 10µl of avidin-phycoerythrin (PE) 
was added to the biotinylated samples. At this time, all samples were allowed to incubate an 
additional 30 minutes at 4oC and were then washed with PBS and resuspended with 200µl of 1% 
paraformaldehyde in PBS. 
Evaluating Lymphocyte Proliferation by Flow Cytometric Analysis 
 All fluorochrome-stained lymphocyte culture preparations were analyzed within 24 hours 
by two-color analysis using a flow cytometer (FACScan, Becton Dickinson, San Jose, CA). The 
lymphocyte gate was based on light scatter parameters, cell size and internal granularity. Mitogen-
stimulated cell divisions were determined by assessing the CFSE content (green fluorescence, 
FL1). Division parameters were set based on well defined peaks within a CFSE fluorescence 
versus events histogram to quantitate the number of cells in each generation. Cell counts above 
200 were considered a division. Mitogen-stimulated samples were compared to medium controls 
to determine a reference point for non-dividing cells. Comparison was also made to the 
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autofluorescence control (unstimulated, unstained cells) to determine the end point of cell division. 
Division parameters were set on dual positive cells for CFSE and Tricolor (deep red fluorescence, 
FL3) to determine the divisional history of lymphocyte subsets. The percentage of activated cells 
was determined by measuring IL-2 receptor expression by enumerating IL-2-phycoerythrin-
labelled cells (red fluorescence, FL2).  
 The number of events (cells) within each division was divided by 2 raised to the power of 
the division to calculate the percentage of original, undivided cells from which they arose. The 
sums of these gave the total undivided cohort for each culture. The sum of cohorts from each 
division was divided by the total number of undivided events to yield the proportion of the 
original population induced into cell division, designated the percentage proliferation (Lyons, 
2000) (Figure and Table 3.1). 
Enzyme Immunoassay for PGE2  
 Peripheral blood mononuclear cells from 3 or 4 dogs of each group were isolated as 
described above. Mononuclear cells were isolated from 3 randomly chosen dogs of each group; 
isolation of too few cells was suspected from one dog of Group Fish oil + E, therefore an 
additional dog was randomly chosen from that group. The cells were incubated for 24 hours at 
37oC and 5% CO2 in RPMI 1640 medium supplemented with 2.0mM L-glutamine, 2.2g/L 
NaHCO3, 25mM HEPES, 2.7 x 10-4 mg/L 2-mercaptoethanol, 100 U/ml penicillin, and 100µg/ml 
streptomycin sulfate with 10% heat-inactivated autologous serum in 24-well plates at a 
concentration of 1x106 cells/well. Macrophages were stimulated by adding lipopolysacchharide 
(LPS) from Escherichia coli (serotype 055:B5, Sigma Chemical, St. Louis, MO) at a concentration 
of 1µg/well. After 24 hours, the plates were frozen at -20oC. Twelve months later, all plates were 
defrosted and contents of each well plus 1ml of sterile saline flush/well were removed and placed 
in separate 15ml conical tubes. The tubes were centrifuged at 340xg for 10 minutes and 
supernatants were frozen at 20oC until time of analysis. 
 The supernatant PGE2 concentration was determined using a competitive enzyme-linked 
immunoassay (EIA, Cayman Chemical, Ann Arbor, MI) according to the manufacturer’s 
instructions (Kay-Mugford et al., 2000). All reagents were provided. Briefly, 50µl of supernatant 
diluted 1:10 and 1:20 were added in duplicate to wells of a goat anti-mouse IgG coated 96-well 
plate provided by the manufacturer. Eight 1:2 serial dilutions of a provided standard were added to 
the wells. Fifty microliters of tracer compound consisting of PGE2 conjugated to 
acetylcholinesterase (AChE), followed by the addition of 50µl of mouse anti-PGE2 were added to 
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Figure 3.1 Histogram of CFSE fluorescence of stimulated lymphocytes (gray peaks) from 
Dog 9038 of Group Fish oil +E at week 12. Lymphocytes were incubated for 72 hours in 
complete medium with 10% autologous serum, 2ug/ml phytohemagglutinin (PHA) and 5µl of 
5mM CFSE. Lymphocyte division was characterized by sequential halving of CFSE fluorescent 
dye, generating equally spaced peaks on the logarithmic scale. Markers above the gray peaks were 
used to enumerate the events within each division. Large dotted peak under the M1 marker 
denotes an unstimulated control cell population that displays maximal fluorescent intensity and no 
subsequent divisions. Small white peak denotes an unstimulated, unstained cell population serving 
as an autofluorescent control. 
 
 
Table 3.1 Data generated from the histogram found in Figure 3.1. 
     Marker   Division (Dn)       Events   Divisor (2Dn) Undivided    Cohorts            
         M1           0        1756        1  (20)        1756 
         M2           1        1590        2  (21)         795 
         M3           2        1639        4  (22)         410 
         M4           3         493        8  (23)          62 
         M5           4         261       16 (24)          16 
Cohort (Divisions 1-4)                                                                                        1283 
Total (Divisions 0-4)                                                                                           3039 
Percent Proliferation                                                                                         42.2% 
Number of Peaks                                                                                                  4 
The number of events (cells) within each division was divided by 2 raised to the power of the 
division to calculate the proportion of original cells from which they arose (undivided cohorts). 
The sum of cohorts from each division (1-4) divided by the total undivided cohort number   (0-4) 
represents the proportion of the original population induced into cell division, called the 
percentage proliferation. 
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each well. Following an18-hour incubation at 4oC, all wells were emptied and washed 5 times 
with buffer. After the addition of 200µl of fresh Ellman’s Reagent (acetylthiocholine and 2-
nitrobenzoic acid), the plate was allowed to develop on an orbital shaker for 90 minutes in the dark 
at room temperature. The intensity of the enzymatic reaction was determined 
spectrophotometrically at 415nm (EL808 Ultra Microplate Reader, Biotech Instruments, 
Winooski, VT). Sample PGE2 concentrations were calculated using a log-logit curve generated by 
the eight standard dilutions.  
Statistical Analysis 
 The number of lymphocyte peaks, determined by flow cytometry, was considered ordinal 
data and was evaluated for each of the 3 groups for a difference between 0 and 12 weeks using the 
Wilcoxon Rank-Sum test. An overall type I error of 0.05 was maintained for all 3 comparisons. 
Groups that behaved differently over time were considered different. PROC NPAR1WAY (SAS 
v8.0, SAS Institute, Cary, NC) was used for the analysis.  
 All other data was considered continuous and found to follow a normal distribution with 
rejection of the null hypothesis of normality at p<0.05 using the Shapiro-Wilk test. The effect of 
diet and time was evaluated using a mixed effect linear model that accounted for the random 
variance of each dog, and the repeated measurements of in each dog. Where there was significant 
interaction of diet and time, least squares means comparisons were made between and within diet 
groups to determine where the significance effects occurred. If the groups behaved differently then 
they were considered to be different. If the groups showed similar significant changes over time, 
then between group comparisons were made at the significant time points. Type I error was 
maintained at 0.05 for all between and within group comparisons. All data were summarized as 
mean +/- SEM.  
Results 
 There were no significant differences in lymphocyte proliferation between the three dietary 
groups measured by the tritiated thymidine or the flow cytometric method at week 0. Lymphocyte 
proliferation, as measured by incorporation of tritiated thymidine, decreased from week 0 to week 
12 in all three groups when the results were expressed as both counts per minute and stimulation 
index. However, this decrease was only significant in the group supplemented with sunflower oil 
(Table 3.2), (Appendix IX). 
 Evaluation of lymphocyte proliferation by measuring the halving of CFSE through flow 
cytometry revealed a reduction in proliferation at week 12 in Groups Sunflower oil and Fish oil, 
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Table 3.2 Lymphocyte proliferation by incorporation of tritiated thymidine. 
                   Counts per Minute 
 
             Stimulation Index 
 
           Week 0        Week 12        Week 0      Week 12 
Sunflower 
      oil 21190.3 + 8281.9* 2940.1 + 1057.8†     55.2 + 19.4*      8.9 + 2.7† 
Fish oil 12138.6 + 2329.5 4175.5 + 1928.5     24.3 + 5.2     12.9 + 7.4 
Fish oil + E 14910.5 + 5030.8 6103.9 + 1692.7     46.8 + 11.5     17.1 + 4.7 
Stimulation index determined by dividing the average CPM of the stimulated population by the 
average CPM of the unstimulated control population. Data are expressed as means +/- SEM, n = 5. 




when results were expressed as number of divisions or peaks. This decreased proliferation was 
once again significant in Group Sunflower oil only. However, when the flow cytometric results 
were expressed as percent proliferation, all three groups had reduced lymphocyte proliferation at 
week 12. In contrast to the tritiated thymidine method and the flow cytometric results expressed as 
number of peaks, only Group Fish oil had a significant decrease in proliferation at week 12 by this 
method (Table 3.3), (Appendix X).  
  
Table 3.3 Lymphocyte proliferation and activation measured by flow cytometry.  
   Number of Peaks 
 
    Percent Proliferation 
 
 
   Percent IL-2R+ 
 
    Week        0 
  Week  
     12 
   Week 
        0 
   Week  
       12 
    Week  
         0 
   Week 
      12 
  Sunflower 
        oil 3.6 + 0.2* 3.0 + 0† 27.9 + 5.0     17.5 + 2.8 60.8 + 7.2   52.3 + 8 
   Fish oil 3.6 + 0.2 3.2 + 0.4 44.8 + 2.5*   26.0 + 5.3† 78.1 + 2.7   65.8 + 5.9 
Fish oil + E 3.2 + 0.4 3.2 + 0.2 34.9 + 7.0     27.5 + 5.9 74.4 + 6.3   56.2 + 8.1 
Number of peaks (divisions) and percent proliferation were determined by evaluation of CFSE 
fluorochrome distribution as cultured lymphocytes divided. Proportion of lymphocytes that bound 
to phycoerythrin-labeled IL-2 determined the percent of IL-2 receptor expression. The data are 
expressed as mean +/- SEM, n = 5. Significant differences within a dietary group across time are 
denoted by different symbols (*, †). IL-2R = IL-2 receptor. 
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 Flow cytometric evaluation of IL-2 receptor expression on activated lymphocytes revealed 
decreased binding of the phycoerythrin-labeled cytokine IL-2 in all three groups from week 0 to 
12. However, none of the reductions within groups were significant. Furthermore, significant 
differences between groups were not detected at either time point (Table 3.3), (Appendix XI). The 
lymphocyte cultures could not be immunophenotyped (CD4, CD8, or CD21) due to nonspecific 
staining or expression of receptors on non-lymphoid cells: as determined by tricolor-staining of 
cells outside the lymphocyte gate. 
 The production of PGE2 by stimulated mononuclear cells was not significantly different 
among the three groups of dogs at week 0. After 12 weeks of dietary treatment, production of 
PGE2 by all three groups was diminished. However, the change from baseline was only 
statistically different for the two groups supplemented with fish oil. The PGE2 concentrations of 
mononuclear cell cultures isolated from dogs receiving 12 weeks of fish oil supplementation were 
significantly lower when compared to the concentration of isolates from dogs supplemented with 
sunflower oil, but there was no difference between Groups Fish oil and Fish oil + E (Figure 3.2), 
(Appendix XII).  
 
                 
                                  




















Figure 3.2 Effect of dietary supplementation for 12 weeks on peripheral mononuclear cell 
production of PGE2 of three canine dietary groups. Data are expressed as means +/- SEM, n = 
3 or 4. Significant differences between groups within a time point are denoted by different lower 
case letters (a, b); significant differences within a group across time are denoted by different 




 Animal and human studies have shown that diets supplemented with or containing a high 
concentration of polyunsaturated fatty acids diminish the capacity of lymphocytes to proliferate 
when stimulated in culture (Calder et al., 1989; Soyland et al., 1993; Yaqoob et al., 1994; Jeffery 
et al., 1997a; Jolly et al., 1997; Kuratko, 2000). Several studies have suggested that n-3 fatty acids 
and eicosapentanoic acid (EPA) in particular are the most potent inhibitors of lymphoproliferation 
(Calder and Newsholme, 1992; Jeffery et al., 1996; Jolly et al., 1997; Kuratko, 2000). One study 
in dogs documented that  n-3 fatty acid dietary supplementation significantly suppressed T-
lymphocyte responsiveness based on a delayed-type hypersensitivity skin test (Wander et al., 
1997). However, in contrast to that report and to studies evaluating in vitro lymphoproliferation in 
other species, the only study to actually measure canine lymphocyte proliferation after dietary 
supplementation with n-3 fatty acids found increased mitogen-induced proliferation (Kearns et al., 
1999). Although PUFA and vitamin E intake, as well as the n-6:n-3 fatty acid ratios fed in these 
two canine studies differed (1.4:1 and 5:1, respectively), the contrasting assessments of 





 Although both methods used in the current study (tritiated thymidine incorportation and 
flow cytometry) indicated diminished lymphocyte proliferation in all three dietary groups, 
statistical significance varied depending on the method used for evaluation. Measurement of 
tritiated thymidine uptake, when reported as counts per minute and stimulation index, revealed a 
significant reduction in lymphocyte proliferation in dogs supplemented with sunflower oil. 
Quantification of the number of peaks derived by sequential halving of CFSE agreed that only the 
sunflower oil group had a significant reduction in proliferation. However, when the percent 
proliferation was calculated from the CFSE histograms, only the fish oil group was found to have 
a significant reduction. The reasons for the discrepancies between the methodologies are likely to 
be multivariate. First, while tritiated thymidine is incorporated into the cell’s DNA as it progresses 
through S-phase, DNA synthesis does not always correlate with complete cell division (Maurer, 
1981). Given this potential circumstance, measurement utilizing tritiated thymidine could 
overestimate the proliferation of a stimulated lymphocyte culture and explain the discrepancy in 
the assessment of proliferation in Group Fish oil. Secondly, using the tritiated thymidine method 
proliferation is only measured during the time the culture is pulsed with tritium, usually the last 4-
6 hours of culture. Unlike the CFSE method, the proliferation that may have occurred previously 
during the 72 hour culture period is not assessed. Finally, ‘cold’ thymidine released from dead 
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cells can dilute the tritiated thymidine added to a lymphocyte culture (Kristensen et al., 1982). In 
this scenario, the CPM would underestimate the number of cell divisions of the lymphocyte 
culture, again explaining the differing results between the methodologies used here. For example, 
stimulated lymphocyte cultures of Dog 9062 at week 0 showed significant proliferation when 
stained with CFSE and evaluated using flow cytometry (Figure 3.3). The percent proliferation of 
this culture was 49.9 % (Mean +/- SEM for Group Fish oil, 44.8% +/- 2.5). This same lymphocyte 
culture also exhibited a high level of activation (82.9%) by increased IL-2 receptor expression 
(Mean +/- SEM for Group Fish oil, 78.1 +/- 2.7) (Figure 3.4). However, after pulsing with tritiated 
thymidine, evaluation of this same stimulated lymphocyte culture revealed a modest 
lymphoproliferative response at best: CPM were13535.6 (Mean +/- SEM for Group Fish oil, 




        
Figure 3.3 Histogram of CFSE fluorescence of stimulated lymphocytes (gray peaks) from 
Dog 9062 of Group Fish oil at week 0. Marked cell proliferation is denoted by the large volume 
of the gray peaks to the left of the unstimulated dotted peak. The minimal volume of gray peaks 
within the region of expected unstimulated cells may represent senescence of unstimulated cells; 
cell senescence could lead to a release of cold thymidine and explain the low CPM of these cells 




       
 
Figure 3.4 Dot plot of CFSE vs. phycoerythrin (PE)-labeled IL-2R of stimulated lymphocytes 
from Dog 9062 of Group Fish oil at week 0 (same cell culture as Figure 3.4). Dots in upper 





on the CFSE histogram this stimulated lymphocyte population (Figure 3.3), senescence of the 
unstimulated cells is apparent. Thus, incorporation of cold thymidine released from these cells 
may account for the discordantly lower values obtained when evaluating CPM and SI. 
 Given these potential pitfalls of the tritiated thymidine method, the percent proliferation as 
derived from the flow cytometric-CFSE method appears to be more accurate at assessing the true 
lymphoproliferative response. This method has proven very useful and accurate in the 
measurement of lymphoproliferative responses in other species (Lyons, 2000; Sathiyaseelan and 
Baldwin, 2000). Counting the number of generation peaks within the CFSE  
histogram appeared to agree with the tritiated thymidine-derived results in the current study. 
However, this rather crude measurement does not take into account the number of cells present 
within each division.  
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 The finding here that a low n-6:n-3 fatty acid ratio diet consisting of 0.65% n-3 fatty acids 
(DMB) acted as a more potent suppressor of lymphocyte proliferation, based on evaluation of the 
percent lymphocyte proliferation as measured by the flow cytometric-CFSE method, agrees with 
reports in other species but contrasts with the findings of the only other similar canine study 
(Kearns et al., 1999). These authors speculated that their unique findings of enhanced 
lymphoproliferative response after supplementation with n-3 fatty acids were due in part to 
maintained plasma levels of vitamin E levels during their study. The results reported in the current 
study would seem to support a positive effect of vitamin E on lymphocyte proliferation, since the 
decrease in lymphocyte proliferation was not significant in dogs receiving the low n-6:n-3 fatty 
acid ratio diet plus vitamin E supplementation (Group Fish oil + E) but was significant in dogs 
receiving n-3 fatty acids alone, based on the flow cytometric technique. Other studies have shown 
vitamin E to have a protective effect against n-3 fatty acid-induced inhibition of lymphocyte 
proliferation (Kramer et al., 1991), or to promote lymphocyte proliferation outright (Corwin and 
Shloss, 1980; Meydani et al., 1990; De la Fuente et al., 2000). An n-3 fatty acid-induced decrease 
in the lymphocyte-mediated immune response of canine subjects, based on delayed-type 
hypersensitivity skin testing, has been attributed to reduced plasma vitamin E concentrations and 
increased lipid peroxidation (Wander et al., 1997). However, despite maintained plasma vitamin E 
concentrations compared to baseline (Figure 2.1) dogs in the current study supplemented with 
sunflower oil and fish oil had diminished lymphoproliferative responses. Furthermore, an increase 
in plasma lipid peroxides was not detected in any of the three dietary groups (Figure 2.4). 
Therefore, based on results of this study, the reduction of lymphocyte proliferation induced by a 
low n-6:n-3 fatty acid diet does not appear to involve reduced vitamin E levels or increased lipid 
peroxidation. Although oxidative damage would potentially be detrimental to the immune 
response, a lack of correlation between lipid peroxidation and n-3 fatty acid-induced diminished 
lymphoproliferation has also been observed by other researchers (Soyland et al., 1993). 
 Other mechanisms have been suggested to account for the effect of polyunsaturated fatty 
acids on lymphocyte proliferation. It has been speculated that inhibition of lymphocyte 
proliferation revolves around the production of PGE2; PGE2 is an inhibitor of lymphocyte 
proliferation and other functions. However, several studies suggest that prostaglandin-independent 
mechanisms are probably more important (Santoli and Zurier, 1989; Calder et al., 1992; Soyland 
et al., 1993). Despite a significant n-3 fatty acid induced-reduction in mononuclear cell production 
of PGE2 (Figure 3.2), lymphocyte proliferation was also reduced in the present study, again 
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suggesting PGE2 independent suppression. Decreased synthesis of the lymphocyte proliferation-
promoting cytokine IL-2 (Santoli and Zurier, 1989; Calder and Newsholme, 1992; Kumar et al., 
1992; Endres et al., 1993; Terada et al., 2001) or decreased expression of its receptor, IL-2R 
(Soyland et al., 1994; Terada et al., 2001), has also been repeatedly implicated as a potential cause 
for the reduction in lymphocyte proliferation induced by polyunsaturated fatty acids, and 
specifically n-3 fatty acids. Furthermore, n-3 fatty acid-induced reduction of IL-2 secretion has 
been related to decreased production of intracellular lipid second messengers (Jolly et al., 1997). 
Although IL-2 production was not measured here, all three diets resulted in a decreased percentage 
of lymphocytes expressing IL-2 receptor. However, these changes were not found to be 
statistically significant and a role for IL-2 or its receptor could neither be confirmed nor denied.  
 Attempts to immunophenotype lymphocyte cultures in this study were unsuccessful. 
Analysis of forward versus side scatter dot plots of cells staining positively for CFSE and tri-color 
fluorochromes revealed the presence of dual positive non-lymphoid cells from cultures of several 
dogs. This occurred with isolates labeled for all three CD markers, so the finding was attributed to 
the non-specific binding of our secondary antibody labeled with the tri-color fluorochrome. Non-
specific binding of labeled antibodies to cultured cells via Fc (IgG) receptors has been previously 
described (Imamura et al., 1991). Furthermore, canine neutrophils express CD4 receptors (Moore 
et al., 1992). Therefore, expression of this receptor with subsequent specific binding of anti-CD4 
antibodies in the specific case of neutrophils cannot be ruled out. 
 Based on the findings in this study, a diet consisting of 0.65% n-3 fatty acids (DMB) with 
an n-6:n-3 fatty acid ratio of 3.4:1 appears to suppress, not promote, lymphocyte proliferation in 
healthy,young adult dogs. Although high plasma levels of vitamin E appear to inhibit this 
suppression of the lymphoproliferative response, this n-3 fatty acid-induced effect is not solely the 
result of diminished vitamin E levels or increased production of lipid peroxides. Regardless, this 
study supports the use of low n-6:n-3 fatty acid ratio diets as part of an anti-inflammatory arsenal 
against chronic inflammatory diseases of the canine.  
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CHAPTER IV: EFFECTS OF DIETARY FISH OIL SUPPLEMENTATION ON 
INFLAMMATORY MEDIATOR PRODUCTION IN THE DOG 
 
Introduction 
 Cytokines are multifunctional peptides that are produced predominantly by activated 
lymphocytes and macrophages during immune and inflammatory reactions (Collins, 1999). Tumor 
necrosis factor (TNF)-α, interleukin (IL)-1β, and IL-6 are among the most important cytokines 
produced by macrophages (Calder, 2001). TNF-α and IL-1 are the first cytokines to be released in 
response to many stimuli. Their release from macrophages peaks 1-2 hours after 
lipopolysaccharide (LPS) challenge (Glauser, 1996). Increased production of IL-6 quickly follows 
in response to high levels of TNF-α and IL-1 (Calder, 1997). Stimuli that promote macrophage 
production of these cytokines, aside from bacterial endotoxin or LPS, include immune complexes 
such as complement and C-reactive protein, fibrin degradation products, and thermal or radiation 
injury (Dinarello, 1996; Collins, 1999). Enhanced release of TNF-α, IL-1 and IL-6 is considered 
one of the hallmarks of sepsis and hemorrhagic shock (Jarrar et al., 1999). These cytokines 
promote a multitude of changes: fever; increased production of acute phase proteins; hypotension; 
activation and infiltration of neutrophils; increased cytokine synthesis by lymphocytes, increased 
synthesis of lipid mediators such as prostaglandins, leukotrienes, and platelet-activating factor 
(PAF); and, many others (Dinarello, 1996; Calder, 1997; Collins, 1999). These effects are crucial 
in the acute response against pathogens and other injuries; however, over production of these 
cytokines can be severely detrimental to the host. Inappropriate or prolonged production has been 
associated with cartilage breakdown, organ dysfunction, anorexia and cachexia, and non-
regenerative anemia (Gelin et al., 1991; Strassmann and Kambayashi, 1995; Dinarello, 1996; 
Jarrar et al., 1999). 
 Cytokines are not the only important mediators of immunity and inflammation. Many of 
the same stimuli also activate cellular phospholipases that lead to the synthesis of prostaglandins, 
leukotrienes, and platelet activating factor (PAF). Prostaglandin E2 (PGE2) is an arachidonic acid 
metabolite produced predominantly by macrophages that is very important in local acute 
inflammatory responses. Localized swelling and erythema is largely due to PGE2-induced 
vasodilation and increased permeability (Collins, 1999; Tilley et al., 2001). Fever is also an 
important component of acute inflammation in which PGE2 plays a critical role. One study 
indicates that the induction of fever in response to PGE2, IL-1, and LPS is in fact mediated 
through a single PGE2 receptor (Ushikubi et al., 1998). There is evidence that PGE2 also plays a 
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role in some chronic inflammatory diseases such as cystic fibrosis (Greally et al., 1994), ulcerative 
colitis, and Crohn’s disease (Hommes et al., 1996). Interestingly, PGE2 has anti-inflammatory and 
immunosuppressive effects as well. PGE2-mediated suppression of in vitro and in vivo TNF-α 
synthesis has been reported (Renz et al., 1988; Spinas et al., 1991). PGE2 has also been found to 
suppress lymphocyte proliferation (Goodwin et al., 1977; Chouaib et al., 1985; Calder et al., 1992) 
and the production of the pro-lymphocyte growth and activation cytokine IL-2 (Rappaport and 
Dodge, 1982; Chouaib et al., 1985; Calder, 2002a). 
 “Platelet-activating factor” is actually a family of structurally similar bioactive 
phospholipid-derived mediators (Collins, 1999; McManus and Pinckard, 2000). PAF synthesis is 
dependent on phospholipase A2-mediated hydrolysis of membrane phospholipids. Similar to PGE2 
and other arachidonic acid metabolites, it is produced by platelets, neutrophils, macrophages, 
endothelial cells and epithelial cells, all of which appear to possess a specific serpentine type 
membrane receptor for PAF. Therefore, it functions as an autocrine and paracrine mediator 
(Bulger and Maier, 2000; McManus and Pinckard, 2000). The name, platelet-activating factor, is 
derived from its earliest discovered function of stimulating rabbit platelet aggregation (Benveniste 
et al., 1972). PAF is now known to have many pro-inflammatory effects on blood vessels, small 
airways and leukocytes, including increased vascular permeability, increased bronchoconstriction, 
and increased adhesion and chemotaxis of neutrophils and eosinophils (Kroegel et al., 1994; 
Christie and Henderson, 2002). PAF has also been shown to enhance the synthesis of TNF-α and 
IL-1 by stimulated macrophages (Floch et al., 1989; Poubelle et al., 1991). Intravenous injection 
of PAF leads to symptoms of shock similar to those seen in clincal cases of sepsis (Mathiak et al., 
1997), so it may play a relatively direct role in the response to endotoxemia. Increased 
concentrations of serum PAF has been associated with development of thrombocytopenia and 
neutropenia in a canine endotoxemia model as well (Tsuchiya et al., 1999).  
 Finding ways to inhibit the synthesis or block the biological effects of these inflammatory 
mediators is an active area of research. The ability to control these mediators offers the potential to 
minimize the negative impact of many chronic inflammatory diseases. However, commercially 
available anti-inflammatory medications can be expensive and many have significant toxicities in 
humans and animals, especially with long-term use. Dietary supplementation with n-3 fatty acids 
obtained from fish or fish oils has been suggested as a way to modulate the immune response 
while avoiding some these toxicities, and appears to have some beneficial anti-inflammatory 
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effects. The principal n-3 fatty acids within fish or fish oils are eicosapentaenoic acid (EPA) and 
docosahexaenoic acid (DHA). 
 Endres and coworkers were among the earliest to show an effect of dietary n-3 fatty acid 
supplementation on cytokine production. They supplemented healthy humans with 18g fish oil a 
day and found significantly decreased TNF-α and IL-1 production from their LPS-stimulated 
peripheral blood mononuclear cells in culture (Endres et al., 1989). Cultured peripheral blood 
mononuclear cells from young and older women supplemented with 2.4g of n-3 fatty acids per day 
produced significantly less IL-1, IL-6, TNF-α and PGE2 compared to baseline levels (Meydani et 
al., 1991). Men and women over the age of 40 receiving a low fat diet supplemented with 1.23g of 
EPA and DHA (n-6:n-3 fatty acid ratio of 3.6:1) also had significant reductions in stimulated 
mononuclear cell production of IL-1, IL-6, TNF-α, and PGE2, but not granulocyte-macrophage-
colony stimulating factor (GM-CSF) (Meydani et al., 1993). Rodent studies have yielded similar 
results. Activated peritoneal macrophages from mice fed a high fat diet supplemented with fish oil 
(10.6g EPA and 10.1g DHA/100g of total fat) synthesized significantly less IL-1, TNF-α, and 
PGE2 compared to mice supplemented with other oils (Wallace et al., 2000). Mice fed this same 
diet also had reduced plasma concentrations of IL-1, IL-6 and TNF-α when injected 
intraperitoneally with LPS compared to mice supplemented with safflower oil (Sadeghi et al., 
1999). Concentrations of PGE2 released from stimulated alveolar macrophages were significantly 
lower in rats consuming a diet of 20% fish oil (Mancuso et al., 1997).  
 Dietary supplementation with n-3 fatty acids reduces PAF synthesis by many cells. Rats 
supplemented with high levels of α-linolenic acid, the fatty acid precursor for EPA and DHA, had 
reduced PAF synthesis by stimulated neutrophils compared to that of controls (Horii et al., 1991). 
Hypoxic brain tissue of young mice previously fed a standard diet supplemented with 10% by 
weight fish oil endogenously synthesized significantly less PAF compared to controls (Akisu et 
al., 2002). Finally, preincubation of cultured human endothelial cells with EPA and DHA 
markedly suppressed TNF-α-stimulated synthesis of PAF (Mayer et al., 2002).  
 Few reports describe clinical trials in which patients were supplemented with n-3 fatty 
acids alone. Oral EPA supplementation of human patients with unresectable pancreatic 
adenocarcinoma resulted in reduced serum concentrations of the acute phase protein C-reactive 
protein, and decreased production of IL-6 by peripheral blood mononuclear cells stimulated in 
culture (Wigmore et al., 1997). Systemic lupus erythrematous (SLE) is a chronic inflammatory 
disease characterized by vasculitis, glomerulonephritis, arthritis, and cutaneous rash; SLE patients 
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supplemented with high doses of EPA and DHA (162mg and 144mg, respectively) had 
significantly prolonged remission times (Das, 1994). Clinical improvement has also been reported 
in human patients with rheumatoid arthritis that receive n-3 fatty acids (Kremer et al., 1987). With 
exception to the previously mentioned studies, the majority of clinical trials have used the 
commerical product IMPACT® which contains arginine, yeast RNA and n-3 fatty acids (Calder, 
2002b). It is difficult to make conclusions about the benefits of n-3 fatty acid supplementation in 
these trials without knowing the effects of the other nutrients. 
 Dietary n-3 fatty acids reduce the production of PGE2, an n-6 fatty acid metabolite, by 
competitive inhibition. Once dietary n-6 and n-3 fatty acids are incorporated into membrane 
phospholipids, they compete directly as substrates for the same enzymes (Bauer, 1992; Reinhart, 
1996). Changes in cytokine production related to n-3 fatty acid supplementation are not the result 
of a reduction in PGE2, since this prostaglandin decreases TNF-α and IL-1 production. Several 
animal studies have demonstrated an effect of dietary fish oil on cytokine gene expression (Calder, 
2002a). Evidence suggests a reduction in gene expression may be the result of down regulation of 
the nuclear transcription factor NFκB (nuclear factor kappa B) (Xi et al., 2001). A study 
evaluating the mechanism of n-3 fatty acid-induced reductions in PAF synthesis also found low 
levels of a transacylase enzyme thought to be crucial to one of the earliest steps of PAF production 
(Oh-hashi et al., 1997).  
 Studies evaluating inflammatory mediator production in normal dogs supplemented with 
n-3 fatty acids have yielded mixed results. Maintaining young and older dogs on a diet consisting 
of 1.65% fish oil (n-6:n-3 ratio of 5:1) for 60 days had no effect on IL-1, IL-6, TNF-α, or PGE2 
production by peritoneal macrophages or peripheral blood mononuclear cells (Kearns et al., 1999). 
In contrast, fish oil supplementation reduced PGE2 production by peripheral blood mononuclear 
cells of dogs receiving a diet consisting of 4.4% fish oil (n-6:n-3 ratio of 1.4:1) for 12 weeks 
(Wander et al., 1997). Production of leukotriene B4 (LTB4), another pro-inflammatory arachidonic 
acid metabolite, was decreased in neutrophils and skin of dogs fed diets with n-6:n-3 fatty acid 
ratios of 5.3:1 and 10.4:1 where n-3 fatty acids comprised 3.4% and 1.8% of the total dietary fatty 
acids, respectively (Vaughn et al., 1994). A few clinical trials assessing the response to n-3 fatty 
acid supplementation in dogs with naturally occurring disease have also been reported. Pruritus 
associated with atopy, a common allergic dermatosis, was controlled in 44.4% of dogs fed a 
commercial diet with an n-6:n-3 fatty acid ratio of 5.5:1 (Scott et al., 1997). Other clinical trials in 
atopic dogs treated with n-3 fatty acid supplements suggest beneficial effects in 11.1 to 18.3% of 
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dogs (Scott and Buerger, 1988; Lloyd, 1989). Diminished pain associated with hip dysplasia has 
been reported in dogs receiving n-3 fatty acid supplements (Miller, 1989). Finally, dogs diagnosed 
with heart failure were supplemtented with 27mg/kg EPA and 18mg/kg DHA each day for 8 
weeks (Freeman et al., 1998). Circulating plasma and stimulated peripheral blood mononuclear 
cell cultures from these dogs revealed only a significant decrease in mononuclear cell production 
of IL-1. TNF-α and PGE2 concentrations in these dogs were not significantly different from 
controls. 
 There is overwhelming evidence that cytokines such as IL-1, IL-6, and TNF-α, as well as 
lipid mediators such as PGE2 and PAF, play an important role in many inflammatory diseases. 
Data suggest that dietary n-3 fatty acid supplementation can influence the production of these 
inflammatory mediators, and potentially reduce the severity of some diseases. However, studies 
evaluating the effects of dietary n-3 fatty acid supplementation on these mediators in the dog are 
limited and contradictory with respect to many reports in other species. The purpose of this study 
was to evaluate the in vitro and in vivo production of IL-1, IL-6, TNF-α, PGE2, and PAF in dogs 
fed a maintenance diet supplemented with 7g of fish oil per day, resulting in a dietary n-6:n-3 fatty 
acid ratio of 3.4:1 and an n-3 fatty acid percentage of 0.65 (DMB). 
Material and Methods 
 The in vitro and in vivo experiments reported in this chapter were conducted using the 
same experimental animals and diet formulations reported in Chapter II. 
Experimental Design 
 Peripheral blood mononuclear cells (PBMCs) for cytokine and PAF synthesis analysis 
were isolated as described in Chapter III. PBMCs were collected at weeks 0 and 12 of the dietary 
trials. 
 After the dogs consumed the experimental diets for 12 weeks, a sterile 16-gauge catheter 
(Venocath-16, Abbott Ireland, Sligo, Ireland), was aseptically placed in one of the jugular veins of 
each dog for the 6 hour experiment. Approximately 20ml of whole blood was obtained through the 
catheter for baseline analysis of circulating IL-1, IL-6, TNF-α, PAF, PGE2 and collection of 
PBMCs. Each dog was treated with an intravenous injection of lipopolysaccharide (LPS) from 
Escherichia coli (serotype 055:B5, Sigma Chemical, St. Louis, MO) in sterile saline at 0.1 µg/kg 
to stimulate the production of inflammatory mediators (LeMay et al., 1990). Following the LPS 
treatment, approximately 20ml of whole blood was drawn at 0.5, 1, 1.5, 2, 3, 4, and 6 hours to 
determine the circulating blood concentrations of cytokines and lipid mediators of inflammation. 
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During this time, the dogs were monitored for signs of illness, and rectal temperatures were taken 
hourly. Following the 6 hour experiment, 500ml of lactated Ringer’s solution was administered 
intravenously to each dog for replacement of fluid loss, and the catheters were removed.  
Serum Cytokine Bioassays (IL-1, IL-6, TNF-α) 
 Ten milliliters of whole blood (from the 20ml drawn at each time point) was placed into 
plain vacutainer tubes, allowed to clot, and centrifuged for the isolation of serum. The serum was 
separated into 0.5ml aliquots and frozen at -80oC until analysis for cytokine activity. These 
bioassays do not utilize specific antibodies and the cytokines were not sequenced. IL-1-, IL-6-, 
and TNF-α-like activities were measured based on the proliferation or death of the target cell lines.  
Cell Culture and Preparation of Cytokine Standards 
 All three target cell lines used for the cytokine bioassays were cultured in RPMI 1640 
medium supplemented with 10% fetal calf serum, 2.0mM L-glutamine, 2.2g/L NaHCO3, 25mM 
HEPES, 2.7 x 10-4 mg/L 2-mercaptoethanol, 100 U/ml penicillin, and 100µg/ml streptomycin 
sulfate. The B13.29 clone B9 cells used for the IL-6 bioassay were additionally supplemented with 
75 U/ml of recombinant murine IL-6 (R&D Systems, Minneapolis, MN). Standard curves for each 
assay were generated by 1:3 serial dilutions of recombinant human IL-1, IL-6, or TNF-α (Sigma 
Chemical, St. Louis, MO). Each recombinant cytokine promoted a dilution-dependent 
proliferation/death of the target cell line. 
Mononuclear Cell Culture and Stimulation 
 Peripheral blood mononuclear cells were incubated for 24 hours at 37oC and 5% CO2 in 
RPMI 1640 medium supplemented with 2.0mM L-glutamine, 2.2g/L NaHCO3, 25mM HEPES, 
2.7 x 10-4 mg/L 2-mercaptoethanol, 100 U/ml penicillin,100µg/ml streptomycin sulfate and 10% 
heat-inactivated autologous serum in 24-well plates. Autologous serum was inactivated by 
incubation in a 56oC water bath for 45 minutes. Mononuclear cells were cultured at a 
concentration of 1x106 cells/well for the determination of PAF concentration and 5x106 cells/well 
for the determination of IL-1, IL-6, and TNF-α activity. Macrophages were stimulated by adding 
lipopolysacchharide (LPS) from Escherichia coli (serotype 055:B5, Sigma Chemical, St. Louis, 
MO) at a concentration of 1µg/well. After 24 hours, the plates were frozen at -20oC. 
Approximately 12 months later, all plates were defrosted and contents of each well plus 1ml of 
sterile saline flush per well were removed and placed in 15ml conical tubes. The tubes were 
centrifuged at 340xg for 10 minutes and supernatants were frozen at -20oC until time of analysis. 
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Bioassay for IL-1 
 The cytotoxicity assay for interleukin-1 was performed using the human melanoma cell 
line A375.S2 (Bueno et al., 1999). Triplicate serum samples from each time point were diluted 
1:10 in 100ul of culture medium and placed in 96-well flat-bottom plates. An additional 100ul of 
culture medium containing 2 x 103 A375.S2 cells was placed in each well (the final dilution of the 
serum sample was 1:20). LPS-stimulated macrophage culture supernatant was assayed for IL-1 
using the same method with a final sample dilution of 1:7. Plates were sealed to prevent 
evaporation and incubated at 37oC in 5% CO2 for 96 hours. Following removal of medium, the 
plates were washed once with CMF-PBS (pH 7.2-7.4). The remaining cells were fixed by adding 
50ul of 100% methanol to each well and allowed to incubate at room temperature for 30 minutes. 
Once the methanol was removed, the cells were stained with 50ul of 0.5% crystal violet in 20% 
ethanol for 30 minutes at room temperature. Following a thorough wash with tap water, 100ul of 
50% methanol was added to each well to elute the incorporated violet stain. Cell survival was 
determined by reading optical density of the plates at 595 nm in a multiwell scanning 
spectrophotometer (Dynatech Laboratories, Chantilly, VA). The sensitivity of the assay for IL-1 
was 7.4 U/ml.  
Bioassay for IL-6 
 The cytoproliferative activity of serum and macrophage supernatant samples was assayed 
using the murine hybridoma IL-6 dependent cell line B13.29 clone B9 (LeMay et al., 1990; Bueno 
et al., 1999). Serum samples were diluted 1:100 with complete medium and placed in a 96-well 
flat-bottom plate at 100ul/well. An additional 100ul of medium containing 2 x 103 B9 cells was 
added to each well (the final dilution of the serum sample was 1:200). Macrophage supernatants 
were assayed for IL-6 using the same method with a final sample dilution of 1:100. Plates were 
sealed and incubated at 37oC in 5% CO2 for 72 hours. For the last 4 hours of incubation, the cells 
were pulsed with 1.0 µCi of tritiated thymidine/well. The plates were harvested onto glass fiber 
filters (Tomtec Harvestor, Orange, CT) and incorporation of tritiated thymidine was determined by 
liquid scintillation spectrophotometry (Betaplate liquid scintillation counter 1205, LKB Wallac, 
Turku, Finland). The sensitivity of the assay for IL-6 was 0.001 U/ml.  
 To determine if the cytoproliferative activity observed was specific to IL-6, the bioactivity 
was neutralized by incubating cells with a mouse anti-human CD126 (IL-6 Receptor) IgG1 
monoclonal antibody (Serotec, Raleigh, NC). Prior to the assay, B9 cells were incubated for 1 
hour at 37oC at a concentration of 7.25µg antibody/2 x 103 cells.  
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Bioassay for TNF-α 
 Tumor Necrosis Factor-α (TNF-α) cytotoxicity activity against the mouse fibrosarcoma 
cell line WEHI 164 clone 13 was determined for serum and macrophage supernatant samples 
(LeMay et al., 1990; Bueno et al., 1999). First, 96-well flat bottom plates were seeded with 2 x 103 
WEHI 164 clone 13 cells in 100µl of complete medium per well and allowed to incubate overnight 
at 37oC in 5% CO2. Approximately 18 hours later, 55µl of media was removed from each well and 
discarded. This volume was replaced by 5µl of actinomycin D at 20µg/ml and 50µl of serum to be 
assayed at a 1:50 dilution (the final dilution of the serum sample was 1:100). Macrophage 
supernatant samples were assayed with a final dilution of 1:50. The plates were sealed and allowed 
to incubate at 37oC in 5% CO2. Approximately 20 hours later, 10µl of tetrazolium dye 3-(4,5 
dimethylthiazole-2yl)-2,5 triphenyl tetrazolium bromide (MTT; 5mg/ml in calcium and 
magnesium free (CMF)-phosphate buffered saline solution (PBS)) was added to each well and 
incubated for an additional 4 hours at 37oC in 5% CO2. After incubation, 100µl of 0.04N HCl in 
isopropanol was vigorously pipetted into each well to dissolve the purple formazan crystals. After 
30 minutes at room temperature, the optical density of the plates was read at 595 nm in a multiwell 
scanning spectrophotometer (Dynatech Laboratories, Chantilly, VA). The sensitivity of the assay 
was 0.06 U/ml. 
 To determine if the cytotoxicity observed was due to TNF-α, the WEHI cells were 
incubated with rat anti-mouse CD120a (TNF-Receptor I) IgG2a monoclonal antibody (HyCult 
Biotechnology b.v.). Prior to the assay, WEHI cells were incubated for 1 hour at 37oC at a 
concentration of 5µg antibody/2 x 103 cells. 
Scintillation Proximity Assay for PAF 
 Due to active acetylhydrolases in peripheral blood, PAF is quickly converted to an inactive 
metabolite, lyso-PAF (McManus and Pinckard, 2000). After collection, whole blood (1.5ml) was 
immediately extracted with 4.5ml of ice cold methanol to inactivate acetylhydrolase activity. 
Plasma was isolated by centrifugation and frozen at -80oC until time of analysis. Semipurification 
of the plasma and macrophage supernatant samples was performed using a modified Bligh-Dyer 
lipid phase extraction (Yamada et al., 1988). Briefly, 3ml samples were mixed with 1ml of 
distilled water and 4ml of chloroform. The lower phase was collected and evaporated to dryness 
under a stream of N2 gas. The residue was dissolved in 200µl of chloroform and applied to a C-18 
Amprep minicolumn (Amersham Pharmacia Biotech UK Limited, Buckinghamshire, England). 
The column was washed with 3ml of chloroform, 2ml of chloroform-methanol (3:2) and 3ml of 
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chloroform-methanol-28% aqueous ammonia (10:5:1), and then eluted with 2ml of chloroform-
methanol-28% aqueous ammonia (50:50:7). The eluate was evaporated under a stream of N2 gas 
and the residue was dissolved in 200µl of assay buffer. 
 The PAF concentration of the purified samples was determined for each time point using a 
scintillation proximity assay (Amersham Pharmacia Biotech UK Limited, Buckinghamshire, 
England) according to manufacturer’s instructions. All reagents were provided. Briefly, 100µl of 
sample were combined with 100µl of the tracer compound ([3H]-PAF), 100µl of anti-PAF 
antibody and 100µl of SPA protein A (bound to fluomicrospheres). Each sample was prepared in 
duplicate and incubated on an orbital shaker for approximately 20hrs at room temperature. After 
incubation, the amount of [3H]-PAF bound to the fluomicrospheres was determined by an 
automated β-scintillation counter (Beckman LS 5000TD Liquid Scintillation System, Beckman 
Instruments, Fullerton, CA) and reported as counts per minute. Average counts per minute were 
calculated for each replicate. The concentration of PAF within each sample was determined using 
a log-logit curve generated by seven standard dilutions. The sensitivity of the assay was 
approximately 20pg/sample. The specificity of this assay for PAF (1-hexadecyl-2-acetyl GPC-
PAF (C16:0)) is 100% with 40% cross reactivity for PAF (1-octadecyl-2-acetyl GPC-PAF 
(C18:0)) but <0.01% with Lyso-PAF and other choline-containing phospholipids. 
Enzyme Immunoassay for PGE2 
 Four milliliters of whole blood were added to an EDTA vacutainer tube with 10µM 
indomethacin to prevent conversion of PGE2 to more stable metabolites. Plasma was isolated by 
centrifugation and frozen at -80oC until time of analysis. Plasma PGE2 concentrations were 
determined using a competitive enzyme-linked immunoassay for a stable PGE2 derivative 
(Bicyclo Prostaglandin E2 EIA Kit, Cayman Chemical, Ann Arbor, MI) according to 
manufacturer’s instructions (Kay-Mugford et al., 2000). Briefly, 500µl sample aliquots were 
derivatized by adding 150µl of 1 M carbonate buffer and incubated overnight at 37oC. Buffered 
samples were further diluted to 1:10 and 1:20 and added in duplicate to wells of a goat anti-mouse 
IgG coated 96-well plate provided by the manufacturer. Eight 1:2 serial dilutions of a provided 
standard were made and added to the appropriate wells. Next, 50 µl of tracer compound consisting 
of PGE2 conjugated to acetylcholinesterase (AChE) was added to each well, followed by the 
addition of 50µl of mouse anti-PGE2. Following an18-hour incubation at 4oC, all wells were 
emptied and washed 5 times with buffer. After the addition of 200µl per well of fresh Ellman’s 
Reagent (acetylthiocholine and 2-nitrobenzoic acid), the plate was allowed to develop on an 
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orbital shaker for 90 minutes in the dark at room temperature. The intensity of the enzymatic 
reaction was determined spectrophotometrically at 415nm (EL808 Ultra Microplate Reader, 
Biotech Instruments, Winooski, VT). Sample PGE2 concentrations were calculated using a log-
logit curve generated by the eight standard dilutions. The sensitivity of the assay was 
approximately 2pg/ml. The specificity of the assay was 100% with <1% cross-reactivity with 
other eicosanoids. 
Statistical Analysis 
 All data were considered continuous and found to follow a normal distribution with 
rejection of the null hypothesis of normality at p<0.05 using the Shapiro-Wilk test. For the 6 hour 
in vivo curves, the area under the curve (concentration-time) was calculated using the trapezoid 
method to make a global comparison between the diet types (Stewart, 1995). The concentration-
time was evaluated using a mixed effect linear model that accounted for the random variance of 
dog. For macrophage production of mediators, the effect of diet and time was also evaluated using 
a mixed effect linear model that accounted for the random variance of dog, and the repeated 
measurements on each dog.  Where there was significant interaction of concentration-time (6 hour 
in vivo) or diet and time (macrophage) at p<0.05, least squares means comparisons were made 
between and within diet groups to determine where the significant effects were occurring. Type I 
error was maintained at 0.05 for all between and within group comparisons. The data were 
summarized as mean +/- SEM. PROC NPAR1WAY (SAS v8.0, SAS Institute, Cary, NC) was 
used for the analysis.  
Results 
 During the 6 hour in vivo experiment, 3 of 5 Group Sunflower oil dogs, 1 of 5 Group Fish 
oil dogs, and 2 of 5 Group Fish oil +E dogs vomited 1-2 hours after receiving their intravenous 
injection of LPS. Rectal temperatures for all dogs remained within normal limits during the 
experiment (Appendix XIII). All dogs appeared bright, alert, and had a good appetite after 
receiving their post-experiment intravenous fluids. 
 Immediately prior to LPS injection, there was no significant difference in serum cytokine 
activity or concentrations of PAF and PGE2 between the three dietary groups. Total serum IL-1 
activity (area under the curve) of the two groups supplemented with fish oil was significantly 
lower than the activity levels of Group Sunflower oil after intravenous LPS injections (Figure 4.1), 
(Appendix XIV). However, significant differences between groups at individual time points were 
only found at hours 4 and 6. The IL-1 activity of Group Sunflower was significantly higher than 
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Group Fish oil at 4 hours and higher than Groups Fish oil and Fish oil + E at 6 hours. Groups Fish 
oil and Fish oil +E were not significantly different at any time point or in total IL-1 activity. 
 Stimulated mononuclear cell culture IL-1 activity was not significantly different between 
groups at weeks 0 or 12. Culture levels of IL-1 activity in all three groups significantly declined 
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Figure 4.1 Serum IL-1 activities of three canine dietary groups following intravenous LPS 
injection. Total IL-1 activity (area under the curve) of Group Sunflower oil was significantly 
higher compared to the total activity of the two fish oil groups. The data are expressed as means 
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Figure 4.2 Effect of dietary supplementation for 12 weeks on mononuclear cell culture IL-1 
activity of three canine dietary groups. The data are expressed as means +/- SEM, n = 3-4. 
Significant differences within a dietary group across time are denoted by different symbols (*,†).  







 Intravenous LPS stimulated a significant increase in the serum IL-6 activity among dogs of 
all three dietary groups. IL-6 activity levels were significantly increased above baseline at 1.5, 2, 
and 3 hours for all three groups and at 4 hours for Groups Sunflower oil and Fish oil + E. IL-6 
activity levels of Group Fish oil were significantly lower than levels of Group Sunflower oil at 
hours 1.5 and 4. Evaluation of total serum IL-6 activity showed Groups Fish oil and Fish oil +E 
levels to be significantly lower than levels of Group Sunflower oil. Groups Fish oil and Fish oil 
+E were not significantly different at any time point or in total IL-6 activity (Figure 4.3), 
(Appendix XVI).  
 Stimulated mononuclear cell culture IL-6 activity was not significantly different between 
dietary groups at week 0. Culture levels of IL-6 activity in all three groups increased significantly 
after 12 weeks of dietary treatment. Increases in IL-6 activity were not significantly different 
between the dietary groups (Figure 4.4), (Appendix XV). The effect of mononuclear cell 
supernatant on the target cell line was completely neutralized by the addition of the anti-human 
IL-6 receptor antibody, supporting the specificity of this assay for canine IL-6 (data not shown).     
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Figure 4.3 Serum IL-6 activities of three canine dietary groups following intravenous LPS 
injection. Total IL-6 activity (area under the curve) of Group Sunflower oil was significantly 
higher compared to the total activity of Groups Fish oil and Fish oil + E. The data are expressed as 
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    †
Figure 4.4 Effect of dietary supplementation for 12 weeks on mononuclear cell culture IL-6 
activity of three canine dietary groups. The data are expressed as means +/- SEM, n = 3-4. 
Significant differences within a dietary group across time are denoted by different symbols (*,†).  
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 Serum TNF-α activities among dogs of all three dietary groups were significantly 
increased 1 hour after receiving an intravenous LPS injection. Activity levels remained 
significantly above baseline at 1.5 hours for Group Fish oil +E. Significant differences between 
groups were not found at any time point, including 1 and 1.5 hours post LPS injection. Total 
serum TNF-α activity was not significantly different between the three groups (Figure 4.5), 
(Appendix XVII). 
  Detectable TNF-α activity was not consistently found in the mononuclear cell culture 
supernatants of any dietary group at either week 0 or week 12. Thus, addition of the anti-mouse 
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Figure 4.5 Serum TNF-α activities of three canine dietary groups following intravenous LPS 
injection. No significant differences in total TNF-α activity (area under the curve) were found. 






 Intravenous LPS injections produced significant changes in serum PAF concentration 
compared to baseline in all three dietary groups. However, the significant elevations at 0.5, 1.5, 
and 2 hours post LPS injection did not differ between groups. Significant differences in total PAF 
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Figure 4.6 Serum PAF concentrations of three canine dietary groups following intravenous 
LPS injection. No significant differences in total PAF concentrations (area under the curve) were 






 Mononuclear cell culture concentrations of PAF were not significantly different between 
dietary groups at week 0. After 12 weeks of dietary supplementation, both groups supplemented 
with fish oil had a decreased supernatant concentration of PAF, while PAF concentration of 
mononuclear cell culture supernatants of Group Sunflower oil increased. However, none of these 
changes were statistically significant, and there were no significant differences between the dietary 
groups. (Figure 4.7), (Appendix XIX).  
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Figure 4.7 Effect of dietary supplementation for 12 weeks on mononuclear cell production of 





 Elevations significantly above the baseline serum PGE2 concentration were found at 0.5, 1, 
1.5, and 2 hours after LPS injection among dogs in Group Sunflower oil. Dogs in Group Fish oil + 
E had significantly increased serum PGE2 concentration 1.5 hours post LPS injection. However, 
there were no significant changes in serum PGE2 among dogs in Group Fish oil. Total serum PGE2 
concentration as well as the 0.5, 1, 1.5, and 2 hr concentrations of Groups Fish oil and Fish oil + E 
were significantly decreased compared to Group Sunflower oil. Significant differences in serum 
PGE2 concentrations between Groups Fish oil and Fish oil + E were not found (Figure 4.8), 
(Appendix XX). 
         Discussion 
 Human and animal studies suggest that dietary supplementation with n-3 fatty acids 
reduces the synthesis of many inflammatory mediators and improves the clinical progression of 
many chronic inflammatory diseases. However, canine studies evaluating the effects of dietary n-3 
fatty acids on cytokine and lipid mediator production have often yielded results contrary to those 
obtained in other species (Kearns et al., 1999) and have been limited in the number of mediators 
evaluated (Vaughn et al., 1994; Wander et al., 1997). Previous work has also varied greatly in both 
the dietary ratio of n-6:n-3 fatty acids and the quantity of n-3 fatty acids used in the experimental 
diets. The ideal n-3 fatty acid enriched diet suited for diminishing the inflammatory response in 
dogs while minimizing potential side effects has not been established.  
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Figure 4.8 Serum PGE2 concentrations of three canine dietary groups following intravenous 
LPS injection. Total serum PGE2 concentrations (area under the curve) of Group Sunflower oil 
was significantly higher compared to the total concentrations of the two fish oil groups. The data 






 The main objective of this study was to evaluate in vivo and in vitro inflammatory 
mediator production in healthy, young adult dogs fed a n-6:n-3 fatty acid ratio diet of 3.4:1 (0.65% 
n-3 fatty acids, DMB). The effects of this diet on the production of interleukin (IL)-1, IL-6, tumor 
necrosis factor-α (TNF-α), prostagladin E2 (PGE2), and platelet-activating factor (PAF) were 
evaluated because of their importance in the inflammatory response. Our results demonstrate that 
feeding a diet with this quantity and ratio of n-6:n-3 fatty acids has significant effects on the 
synthesis of several of these mediators in young adult dogs. 
 The total serum activity (area under the curve) for each cytokine in each dietary group 
peaked following LPS administration at time points in agreement with previous reports (LeMay et 
al., 1990; Glauser, 1996). Total serum IL-1 activity of the two groups supplemented with fish oil 
was significantly lower than the control group supplemented with sunflower oil. However, 
significant differences between the 3 dietary groups at individual time points were not apparent 
until hours 4 and 6. The total serum IL-1 activity of Group Sunflower did not significantly 
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increase above baseline until 4 and 6 hours after the LPS injection. This delayed increase in 
activity is unexpected based on previous reports (Glauser, 1996). It is possible that the cytotoxicity 
of the A375.S2 cell line at these time points was not related to an increase in IL-1 activity. 
Therefore, the actual total serum IL-1 activity may not be significantly different between groups.  
 The IL-1 activity of LPS-stimulated peripheral blood mononuclear cell cultures was 
significantly decreased by dietary supplementation in all three groups after 12 weeks. Suppression 
of IL-1 production by stimulated mononuclear cells of dogs receiving n-3 fatty acid 
supplementation was expected based on human reports (Endres et al., 1989; Meydani et al., 1991; 
Meydani et al., 1993). The lack of significant difference between groups is not surprising given the 
unexpected increase in n-3 fatty acid concentration within the plamsa phospholipids of the control 
group (Group Sunflower oil). The n-3 fatty acid-induced reductions in IL-1 activity within 
mononuclear cell supernatants, but not in serum IL-1 activity, are consistent with previously 
reported data in the canine (Freeman et al., 1998). 
 IL-6, unlike TNF-α, is synthesized by many cell lines including macrophages, endothelial 
cells, fibroblasts, and activated T-lymphocytes in response to endotoxin and other cytokines, like 
TNF and IL-1 (Abbas et al., 2000). As previously reported (Sadeghi et al., 1999), total serum IL-6 
activity after the intravenous LPS injection was significantly lower in the dietary groups 
supplemented with fish oil as compared to Group Sunflower oil, even though there was no 
difference between the groups in TNF-α and IL-1 activities. This implies that dietary n-3 fatty acid 
supplementaion may have attenuated the direct induction of IL-6 synthesis by LPS.   
 Evaluation of IL-6 activity from LPS-stimulated peripheral blood mononuclear cells in all 
3 dietary groups revealed surprising results. The observation that increased LPS-stimulated 
mononuclear cell production of IL-6 was increased in all groups does not correlate with the serum 
IL-6 levels in these same dogs. It was anticipated that the mononuclear cell culture activity of IL-6 
would either remain similar to baseline or decrease, with the most pronounced reduction in 
cultures from dogs supplemented with fish oil. This discrepancy in IL-6 activity between serum 
and LPS-stimulated peripheral blood mononuclear cells could be the result of variable effects of n-
3 fatty acids on different cell lines. Serum IL-6 activity may reflect IL-6 synthesis by endothelial 
cells, as opposed to macrophage production of IL-6 within mononuclear cell cultures. It is also 
possible optimal conditions for the growth of the target cell line were different from weeks 0 to 
12, despite similar levels of IL-6. Regardless, the n-3 fatty acid-induced increase in macrophage 
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synthesis of IL-6 is in contrast to the findings of previous studies (Meydani et al., 1993; Kearns et 
al., 1999).  
 There was no significant difference in total serum TNF-α activity between the dietary 
groups in this study. This is consistent with previous work in dogs that failed to show a significant 
effect of dietary n-3 fatty acids on mononuclear cell production of TNF-α (Freeman et al., 1998; 
Kearns et al., 1999). Addition of an anti-mouse TNF-α receptor antibody failed to inhibit target 
cell death induced by human recombinant TNF-α. The affinity of the antibody may not have been 
strong enough to inhibit the cytokine from binding to the receptor and preventing cell killing. 
Secondly, binding of the antibody to the receptor may not have inhibited binding of TNF-α to the 
receptor. Nevertheless, since the human recombinant TNF-α used in the study consistently 
produced dilution-dependent cell death of the WEHI cell line, the assay should have been 
appropriate for detecting TNF-α activity in canine samples.    
 Based on the detection of TNF-α activity in serum samples, detectable levels of TNF-α 
activity in the stimulated mononuclear cell supernatants were expected. While the TNF-α activities 
within mononuclear cell supernatants as reported here may be accurate, excessive proliferation of 
the target cell line is also possible. Mononuclear cells in this experiment were frozen in culture 
media for approximately 1 year at -20oC. Prolonged contact of these cells with supernatant may 
have allowed liberation of growth promoting substances, and impacted the death of the target cell 
line. Mononuclear cell components may also have affected the integrity of TNF-α. Freezing of 
stimulated mononuclear cells for unspecified periods of time has been reported (Meydani et al., 
1991; Freeman et al., 1998). However, separation of the supernatants from the mononuclear cells 
18-24 hours after stimulation (Kurzman et al., 1993; Tappia and Grimble, 1994; Kearns et al., 
1999) may have allowed for detectable levels of TNF-α activity.  
 Dietary n-3 fatty acid supplementation has previously been reported to suppress PAF 
synthesis in other species (Horii et al., 1991; Oh-hashi et al., 1999; Akisu et al., 2002; Mayer et 
al., 2002). Serum PAF concentrations did not differ significantly between groups in this study. 
Decreased PAF concentrations were observed in the stimulated mononuclear cell cultures of dogs 
receiving n-3 fatty acid supplementation, but this change did not attain statistical significance.  
 Several human and animal studies have documented significant reductions in PGE2 
synthesis by mononuclear cells following n-3 fatty acid supplementation (Meydani et al., 1991; 
Meydani et al., 1993; Wander et al., 1997; Wallace et al., 2000). The current study also 
documented significant reductions in PGE2 concentrations within mononuclear cell supernatants 
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(results discussed in Chapter III) and serum following LPS stimulation of dogs supplemented with 
n-3 fatty acids when compared to baseline values. This effect of dietary n-3 fatty acid 
supplementation on both cellular and systemic levels of PGE2 was expected based on the well 
characterized relationship between fatty acids and prostaglandin production (Bauer, 1992; 
Reinhart, 1996). 
 Direct influence of vitamin E or lipid peroxidation on cytokine production is rarely 
addressed (Meydani et al., 1991). Low levels of vitamin E may allow increased lipid peroxidation, 
which could inhibit lymphocyte or macrophage function, including cytokine production. 
Significant differences in cytokine production were not observed between the two fish oil groups 
consuming different concentrations of dietary vitamin E. However, this is not surprising 
considering that neither group had elevations in plasma lipid peroxides or decreased 
concentrations of vitamin E. 
 In conclusion, a decreased dietary n-6:n-3 fatty acid ratio, a simple increase in intake of n-
3 fatty acids, or both was associated with significant reduction in peripheral blood mononuclear 
cell culture IL-1 activity and PGE2 concentration in this study. This dietary manipulation also 
resulted in decreased serum PGE2 concentrations and IL-6 activity. Lower dietary n-6:n-3 fatty 
acid ratios or increased absolute intake of n-3 fatty acids holds promise for clinical suppression of 
pro-inflammatory mediator synthesis.  
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 This study examined the impact of dietary n-3 fatty acid supplementation on hematologic, 
serum biochemical, and immunological parameters in healthy, young adult dogs. The long chain 
n-3 fatty acids eicosapentaenoic acid (EPA) and docosahexaenoic (DHA) are principally obtained 
from fish or fish oil. These fatty acids act as anti-inflammatory agents in part by directly inhibiting 
the metabolism of arachidonic acid (AA). The pathways leading to decreased production of AA 
metabolites, namely 2-series prostaglandins and 4-series leukotrienes, are well characterized 
(Bauer, 1992; Reinhart, 1996). 
 The benefits of dietary n-3 fatty acid supplementation do not come without potential side 
effects. The long, unsaturated carbon chains of EPA and DHA are easy targets for oxygen free 
radicals (Mylonas and Kouretas, 1999). The oxidation of these fatty acids contained within cell 
membrane phospholipids initiates an autocatalytic reaction called lipid peroxidation. Increased 
levels of lipid peroxidation can lead to cell dysfunction and death. Dietary vitamin E 
supplementation is suggested when high levels of n-3 fatty acids are consumed to help prevent this 
process (National-Research-Council, 1985; Muggli, 1989). Evidence of increased lipid 
peroxidation and significantly reduced plasma vitamin E levels has been reported in dogs 
supplemented with n-3 fatty acids (Wander et al., 1997). However, plasma lipid peroxide and 
serum vitamin E concentrations among the dogs in the current study did not change significantly 
from baseline, despite a diet consisting of 1.65% oil (combined sunflower and fish oil) and an n-
6:n-3 fatty acid ratio of 3.4:1. The vitamin E content of these diets was well above the 
recommended intake for this level of fatty acid supplementation. 
 Dietary n-3 fatty acids have been shown to inhibit platelet aggregation in both animals and 
man, perhaps most notably in Greenlandic Eskimos consuming a diet high in fish products 
(Dyerberg and Bang, 1979; Adan et al., 1999). Similar abnormalities have not previously been 
documented in healthy or tumor-bearing dogs (Boudreaux et al., 1997; McNiel et al., 1999). These 
findings were confirmed here, since no significant inhibition of platelet aggregation could be 
found in dogs consuming the n-3 fatty acid enriched diets.  
 Dietary n-3 fatty acid supplementation has been shown to reduce serum triglyceride 
concentrations in healthy humans, humans suffering from primary hyperlipidemia, rats and pigs 
(Bang et al., 1971; Harris, 1996). In contrast to previous canine reports, dietary n-3 fatty acid 
supplementation resulted in significant reduction of serum triglyceride concentrations in the dogs 
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studied here. This finding has potential clinical application in the treatment of canine idiopathic 
hyperlipidemia.  
 Dietary supplementation of fish oil resulted in increased levels of  
n-3 fatty acids within plasma phospholipids. However, a similar change was observed in the 
control group supplemented with sunflower oil, a source rich in n-6 fatty acids. This result may be 
attributed to several factors, including alterations in desaturase enzyme activity and preferential n-
3 fatty acid esterification within phospholipids. 
 The main object of this study was to evaluate dietary n-3 fatty acid supplementation-
induced effects on lymphocyte proliferation and inflammatory mediator production. Most work 
examining n-3 fatty acid supplementation in humans and animals shows significant suppression of 
lymphocyte proliferation and interleukin (IL)-2 production, an important autocrine and paracrine 
growth promoter in lymphocytes (Meydani et al., 1991; Calder and Newsholme, 1992; Jeffery et 
al., 1997). The few canine studies that have assessed lymphocyte proliferation and function after 
dietary n-3 fatty acid supplementation report contrasting results (Wander et al., 1997; Kearns et 
al., 1999). Lipid peroxide and plasma vitamin E concentrations have been related to reduced 
lymphocyte proliferation and function, and have also been investigated in people (Meydani et al., 
1993). Finally, although prostaglandin-independent mechanisms are also suggested (Calder et al., 
1992), prostaglandin E2 (PGE2) is known to be a potent suppressor of lymphocyte proliferation 
(Goodwin et al., 1977; Chouaib et al., 1985). Significant suppression of lymphocyte proliferation 
was observed in the current study among dogs supplemented with fish oil despite unaltered plasma 
lipid peroxide and serum vitamin E concentrations, and decreased serum levels and mononuclear 
cell production of PGE2. These data suggest that n-3 fatty acid-induced suppression of lymphocyte 
proliferation is independent of lipid peroxidation, vitamin E status, and PGE2 production. Some 
studies indicate that the effects of n-3 fatty acids on lymphocyte proliferation are mediated, at least 
in part, through decreased IL-2 production or suppressed expression of the IL-2 receptor (IL-2R) 
(Calder and Newsholme, 1992; Terada et al., 2001). A decreased percentage of lymphocytes 
expressing IL-2 receptor was demonstrated here; however, these changes were not statistically 
significant and a role for IL-2 or its receptor could neither be confirmed nor denied.  
 The importance of IL-1, IL-6, tumor necrosis factor (TNF)-α, and platelet-activating factor 
(PAF) in the inflammatory response are well described. Dietary n-3 fatty acid supplementation 
reduces the synthesis of these inflammatory mediators in human and numerous animal species 
(Endres et al., 1989; Horii et al., 1991; Meydani et al., 1991; Wallace et al., 2000). However, 
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diminished synthesis in dogs supplemented with dietary n-3 fatty acids appears inconsistent based 
on published reports (Wander et al., 1997; Freeman et al., 1998; Kearns et al., 1999). Dietary n-3 
fatty acid supplementation of the current study population was associated with significant 
reductions in peripheral blood mononuclear cell culture IL-1 activity and PGE2 concentration, in 
vitro. More importantly, this dietary manipulation resulted in decreased in vivo production PGE2 
and IL-6.  
 Future research directed towards evaluation of varying n-6:n-3 fatty acid ratios and 
absolute quantities of dietary n-3 fatty acids is clearly needed. Significant changes in serum 
triglycerides, lymphocyte proliferation and production of certain inflammatory mediators were 
observed here. Low dietary n-6:n-3 fatty acid ratios or an increased absolute dietary level of n-3 
fatty acids may permit beneficial manipulation of the inflammatory response. Future investigation 
may lead to clinically beneficial therapy for chronic inflammatory diseases and hyperlipidemia. 
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APPENDIX I: DIET FORMULATIONS 
 























grams    
/day 
Cr. Fiber 2.3 
Moisture 9.31 










  kibble + 
oil 
T Sat. FA 2.76 11 26.3 22.08 15.164 15.707 15.707 
T MonoUn 3.37 23.1 19.9 26.96 19.7144 18.3816 18.3816 
T PolyUn 2.04 57.1 41.4 16.32 17.2804 13.4406 13.4406 
T Unsat 5.41 80.2 61.3 43.28 36.9948 31.8222 31.8222 
Total Fat 8.17 91.2 87.6 65.36 52.1588 47.5292 47.5292 
C14:0 0.13 0.07 6.63 1.04 0.65868 1.11452 1.11452 
C15:0 0.02 0 0.7 0.16 0.1 0.149 0.149 
C16:0 1.7 6.16 15.1 13.6 9.26384 9.59396 9.59396 
C16:1 0.24 0.11 10.1 1.92 1.21364 1.90766 1.90766 
C16:2 0 0 1.91 0 0 0.1337 0.1337 
C16:3 0 0 1.66 0 0 0.1162 0.1162 
C17:0 0.05 0 0.55 0.4 0.25 0.2885 0.2885 
C18:0 0.81 3.41 2.97 6.48 4.47284 4.27836 4.27836 
C18:1 3.07 22.6 8.44 24.56 18.1524 16.0764 16.0764 
C18:2 n6 1.88 56.8 1.39 15.04 16.4432 9.8381 9.8381 
C18:3 n6 0 0 0.14 0 0 0.0098 0.0098 
C18:3 n3 0.1 0.16 1.63 0.8 0.51984 0.61506 0.61506 
C18:4 n3 0.02 0.18 3.28 0.16 0.12232 0.33068 0.33068 
C20:0 0.02 0.24 0.19 0.16 0.12976 0.11474 0.11474 
C20:1 0.05 0.38 1.2 0.4 0.29712 0.33628 0.33628 
C20:2 n6 0.01 0 0.19 0.08 0.05 0.0633 0.0633 
C20:3 n6 0 0 0.24 0 0 0.0168 0.0168 
C20:3 n3 0 0 0.24 0 0 0.0168 0.0168 
C20:4 n6 0.02 0 0.75 0.16 0.1 0.1525 0.1525 
C20:4 n3 0 0 1.59 0 0 0.1113 0.1113 
C20:5 n3 0 0 10.7 0 0 0.749 0.749 
C21:5 n3 0 0 0.61 0 0 0.0427 0.0427 
C22:0 0 0.77 0 0 0.09548 0.00462 0.00462 
C22:4 n6 0 0 0.27 0 0 0.0189 0.0189 
C22:5 n6 0 0 0.34 0 0 0.0238 0.0238 
C22:5 n3 0 0 2.18 0 0 0.1526 0.1526 
C22:6 n3 0.01 0 13 0.08 0.05 0.96 0.96 
C24:0 0.02 0.3 0 0.16 0.1372 0.1018 0.1018 
Vitamin E       










APPENDIX II: BODY WEIGHT  
 
(lbs) Week 3 Week 6 Week 9 Week 12 
Group  
Sunflower Oil 
Dog 9002 50.4 47.7 46.3 48 
Dog 9028 51.1 50.6 49.7 52 
Dog 9040 57.8 58.1 61.4 61.9 
Dog 9057 53.9 55.7 56.7 58.9 
Dog 9060 57 55.6 55.9 55.9 
Mean 54.04 53.54 54 55.34 
SD 3.347088 4.255937 5.988322 5.501182 
SEM 1.496863 1.903313 2.678059 2.460203 
Group  
Fish Oil 
Dog 9003 55.6 58.3 61.4 60.8 
Dog 9031 46.2 46.8 48.5 47.7 
Dog 9039 48.7 47.7 46.7 46.2 
Dog 9049 58.7 61.4 55.2 55.6 
Dog 9062 58.1 55.4 59.1 60 
Mean 53.46 53.92 54.18 54.06 
SD 5.677411 6.455773 6.43405 6.806468 
SEM 2.539016 2.887109 2.877395 3.043945 
Group  
Fish Oil  + E 
Dog 9005 53.7 48.7 46.8 50.7 
Dog 9038 47.6 46 46.1 47.2 
Dog 9050 53.5 54.7 52.7 52.7 
Dog 9058 50 50.5 51.6 51.5 
Dog 9061 59.4 57.7 60.3 60.8 
Mean 52.84 51.52 51.5 52.58 
SD 4.464639 4.684229 5.703946 5.030606 














































APPENDIX III: SERUM VITAMIN E  
 
(ug/mL) Week 0 Week 6 Week 12 
Group  
Sunflower oil 
Dog 9002 9.35 8.43 8.32 
Dog 9028 4.24 4.18 5.14 
Dog 9040 5.98 10.78 8.74 
Dog 9057 2.85 5.46 5.97 
Dog 9060 4.33 6.9 6.1 
Mean 5.35 7.15 6.854 
SD 2.4959672.5765671.580658 
SEM 1.11623 1.1522760.706892 
Group  
Fish oil 
Dog 9003 7.18 6.92 6.29 
Dog 9031 4.95 5.39 5.69 
Dog 9039 4.33 3.82 7.54 
Dog 9049 4.19 4.9 3.8 
Dog 9062 1.38 4.14 7.56 
Mean 4.406 5.034 6.176 
SD 2.0736511.2221621.554873 
SEM 0.9273650.546567 0.69536 
Group  
Fish oil + E 
Dog 9005 7.66 10.76 13.37 
Dog 9038 7.89 8.01 14.54 
Dog 9050 6.13 13.8 13.43 
Dog 9058 5.63 14.39 14.71 
Dog 9061 4.92 10.38 11.28 
Mean 6.446 11.468 13.466 
SD 1.2897022.6276931.368404 
SEM 0.576772 1.17514 0.611969 
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APPENDIX IV: PLATELET AGGREGATION  
 
(%LT) Week 0 Week 6 Week 12 
 ADP Collagen ADP Collagen ADP Collagen 
Group  
Sunflower oil 
Dog 9002 76 59 64 31 60 47 
Dog 9028 70 45 70 39 79 52 
Dog 9040 40 34 72 33 52 52 
Dog 9057 78 50 77 54 68 52 
Dog 9060 57 62 60 50 68 38 
Mean 64.2 50 68.6 41.4 65.4 48.2 
SD 15.8177116 11.2472219 6.69328021 10.2127371 10.0895986 6.09918027
SEM 7.07389567 5.02991053 2.99332591 4.5672749 4.51220567 2.72763634
Group  
Fish oil 
Dog 9003 80 62 85 47 69 45 
Dog 9031 58 46 62 33 79 42 
Dog 9039 55 47 39 14 86 51 
Dog 9049 48 30 49 39 61 25 
Dog 9062 58 58 85 78 53 67 
Mean 59.8 48.6 64 42.2 69.6 46 
SD 12.0083304 12.481987 20.8326667 23.4243463 13.2966161 15.1986842
SEM 5.37028863 5.58211429 9.31665176 10.4756861 5.9464275 6.79705819
Group  
Fish oil + E 
Dog 9005 68 60 48 15 70 50 
Dog 9038 74 69 78 28 78 59 
Dog 9050 52 46 68 8 60 30 
Dog 9058 69 60 52 40 52 52 
Dog 9061 61 52 80 58 62 44 
Mean 64.8 57.4 65.2 29.8 64.4 47 
SD 8.5264295 8.76356092 14.6696967 19.97999 9.93981891 10.9087121
SEM 3.81313519 3.91918359 6.56048779 8.93532316 4.44522215 4.87852437
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APPENDIX V: HEMATOLOGY / CHEMISTRY WEEK 0 
 
Analyte Glucose ALT ALP BUN Creatinine HCT PLT WBC 
units mg/dL U/L U/L mg/dL mg/dL % x103/uL x103/uL 
Group  
Sunflower Oil 
9002 88 22 43 18 0.8 40 331 16.1 
9028 98 53 67 19 0.9 49.5 285 16.8 
9040 89 38 43 28 1.1 55.7 198 13.6 
9057 87 36 39 15 1.1 48.3 245 15.6 
9060 76 72 22 20 0.8 52.3 261 15.1 
Mean 87.6 44.2 42.8 20 0.94 49.16 264 15.44 
SD 7.829432 19.03155 16.0686 4.84768 0.151658 5.860717 49.13247 1.205404
SEM 3.501428 8.511169 7.186098 2.167948 0.067823 2.620992 21.97271 0.539073
Group  
Fish Oil 
9003 84 23 56 23 0.8 49.5 282 13.7 
9031 94 128 49 20 1 50 271 15.1 
9039 96 33 31 34 1 52.6 290 18.9 
9049 77 43 38 16 1.1 54.9 203 15.4 
9062 94 40 34 26 0.8 56.2 317 14.9 
Mean 89 53.4 41.6 23.8 0.94 52.64 272.6 15.6 
SD 8.185353 42.40637 10.54988 6.797058 0.134164 2.941598 42.4535 1.954482
SEM 3.660601 18.9647 4.71805 3.039737 0.06 1.315523 18.98578 0.874071
Group  
Fish Oil + E 
9005 94 22 69 18 0.8 39.8 553 17.7 
9038 97 25 42 22 0.9 45.8 293 12.6 
9050 86 45 20 18 1.1 55.3 182 14.3 
9058 98 45 50 21 1.1 50.2 223 11.6 
9061 87 36 42 27 0.9 54.5 294 13.4 
Mean 92.4 34.6 44.6 21.2 0.96 49.12 309 13.92 
SD 5.59464 10.83051 17.62952 3.701351 0.134164 6.445696 144.5182 2.336022















APPENDIX VI: HEMATOLOGY / CHEMISTRY WEEK 6 
 
Analyte Glucose ALT ALP BUN Creatinine HCT PLT WBC 
units mg/dL U/L U/L mg/dL mg/dL % x103/uL x103/uL 
Group  
Sunflower Oil 
9002 86 42 38 15 1 44.5 284 13.4 
9028 87 49 49 17 1.1 52.5 294 14.6 
9040 96 39 45 20 0.9 48 255 10.7 
9057 89 36 52 29 1 45.5 214 12.4 
9060 86 62 33 21 0.8 50.2 309 13.3 
Mean 88.8 45.6 43.4 20.4 0.96 48.14 271.2 12.88 
SD 4.207137 10.35857 7.829432 5.366563 0.114018 3.297423 37.5726 1.448102
SEM 1.881489 4.632494 3.501428 2.4 0.05099 1.474653 16.80298 0.647611
Group  
Fish Oil 
9003 74 27 41 21 1 49.3 355 19.3 
9031 84 37 38 25 1 46.2 339 12.2 
9039 93 34 23 24 1 52.9 386 15 
9049 98 49 42 23 1 45.9 225 13.4 
9062 89 92 48 27 0.7 48.5 299 13.2 
Mean 87.6 47.8 38.4 24 0.94 48.56 320.8 14.62 
SD 9.181503 25.95573 9.343447 2.236068 0.134164 2.829841 62.05804 2.802142
SEM 4.106093 11.60776 4.178516 1 0.06 1.265543 27.7532 1.253156
Group  
Fish Oil + E 
9005 99 46 32 24 1.1 46.1 443 17.6 
9038 84 26 41 17 0.9 50.5 306 11.9 
9050 88 43 26 24 1 51.2 247 14.6 
9058 98 44 35 22 1 53.1 268 14.3 
9061 98 52 48 18 1 49.1 199 11.7 
Mean 93.4 42.2 36.4 21 1 50 292.6 14.02 
SD 6.913754 9.705668 8.443933 3.316625 0.070711 2.613427 92.52729 2.403539















APPENDIX VII: HEMATOLOGY / CHEMISTRY WEEK 12 
 
Analyte Glucose ALT ALP BUN Creatinine HCT PLT WBC 
units mg/dL U/L U/L mg/dL mg/dL % x103/uL x103/uL 
Group  
Sunflower Oil 
9002 95 36 41 25 1 53 249 12.1 
9028 90 42 58 17 1.2 54.9 276 12.4 
9040 78 28 49 23 1 45.9 236 14.7 
9057 74 37 41 27 0.9 48.3 217 19.7 
9060 97 42 14 30 0.9 48.7 219 11.7 
Mean 86.8 37 40.6 24.4 1 50.16 239.4 14.12 
SD 10.28105 5.744563 16.4408 4.878524 0.122474 3.683477 24.29609 3.330465 
SEM 4.597826 2.569047 7.352551 2.181742 0.054772 1.647301 10.86554 1.489429 
Group  
Fish Oil 
9003 76 27 26 24 1.1 53.3 324 13 
9031 91 42 30 22 1 44.9 311 14.4 
9039 94 27 31 25 1.1 46.2 339 15.1 
9049 75 46 36 22 1.1 46.5 217 16.6 
9062 87 35 30 28 0.9 53.6 284 13.4 
Mean 84.6 35.4 30.6 24.2 1.04 48.9 295 14.5 
SD 8.677557 8.619745 3.577709 2.48998 0.089443 4.198214 48.05726 1.43527 
SEM 3.880722 3.854867 1.6 1.113553 0.04 1.877498 21.49186 0.641872 
Group  
Fish Oil + E 
9005 84 35 36 30 1.1 51.1 410 15.2 
9038 87 25 97 15 0.9 47.9 357 16.2 
9050 78 41 21 20 1 51.3 219 21.1 
9058 80 33 34 25 1.1 49.3 276 16.9 
9061 86 49 39 22 0.9 49.2 324 15.1 
Mean 83 36.6 45.4 22.4 1 49.76 317.2 16.9 
SD 3.872983 8.988882 29.65299 5.59464 0.1 1.427585 73.45543 2.462722 















APPENDIX VIII: LIPID PEROXIDES  
 
(uM) Week 0 Week 6 Week 12
Group  
Sunflower oil 
Dog 9002 4.03 4.42 5.63 
Dog 9028 6.5 5.33 5.67 
Dog 9040 5.54 3.25 1.95 
Dog 9057 1.17 5.03 4.33 
Dog 9060 2.17 3.38 6.63 
Mean 3.882 4.282 4.842 
SD 2.231069 0.942799 1.811717
SEM 0.997765 0.421633 0.810225
Group  
Fish oil 
Dog 9003 4.68 8.06 4.94 
Dog 9031 6.89 5.37 3.53 
Dog 9039 6.24 1.17 3.55 
Dog 9049 1.69 4.77 4.31 
Dog 9062 5.46 5.92 5 
Mean 4.992 5.058 4.266 
SD 2.023579 2.502593 0.715772
SEM 0.904972 1.119193 0.320103
Group  
Fish oil + E 
Dog 9005 8.66 2.34 5.01 
Dog 9038 7.54 3.32 6.67 
Dog 9050 3.47 6.24 4.85 
Dog 9058 4.29 6.08 3.81 
Dog 9061 1.95 5.98 3.51 
Mean 5.182 4.792 4.77 
SD 2.820863 1.826614 1.243302














APPENDIX IX: LYMPHOCYTE PROLIFERATION  
BY TRITIATIED THYMIDINE  
 
(CPM)  Week 0 Week 12
Group  
Sunflower oil 
Dog 9002 6817.82 2149.85 
Dog 9028 13166.4 3374.64 
Dog 9040 11790.7 466.24 
Dog 9057 21167 1963.38 






Dog 9003 6179.61 6189.97 
Dog 9031 18083 10510.9 
Dog 9039 7277.45 262.6 
Dog 9049 15617.3 371.29 
Dog 9062 13535.6 3542.54 




Fish oil + E 
Dog 9005 32717.8 6289.8 
Dog 9038 18800.7 9971.1 
Dog 9050 8833.16 4373.76 
Dog 9058 4359.63 9221.78 




(SI) Week 0 Week 12 
Group 
Sunflower oil 
Dog 9002 15.3613 7.34991 
Dog 9028 30.212 12.048 
Dog 9040 55.4074 1.55367 
Dog 9057 47.0054 6.26817 
Dog 9060 127.815 17.1299 
Mean 55.16022 8.86993 
SD 43.45011 5.935792 
SEM 19.43148 2.654567 
Group  
Fish oil 
Dog 9003 13.1043 15.17 
Dog 9031 30.9455 40.6816 
Dog 9039 18.7529 1.08365 
Dog 9049 41.3222 0.86194 
Dog 9062 17.3451 6.94861 
Mean 24.294 12.94916 
SD 11.60175 16.55988 
SEM 5.18846 7.405802 
Group  
Fish oil + E 
Dog 9005 84.142 22.6301 
Dog 9038 51.5737 24.3911 
Dog 9050 51.671 10.0766 
Dog 9058 16.1611 26.127 
Dog 9061 30.4068 2.0608 
Mean 46.79092 17.05712 
SD 25.73139 10.49673 













APPENDIX X: LYMPHOCYTE PROLIFERATION  






(Peaks)     Week 0 Week 12 
Group  
Sunflower oil 
Dog 9002 3 3 
Dog 9028 4 3 
Dog 9040 4 3 
Dog 9057 3 3 
Dog 9060 4 3 
Mean 3.6 3 
SD 0.547 0 
SEM 0.244 0 
Group  
Fish oil 
Dog 9003 4 3 
Dog 9031 4 3 
Dog 9039 3 2 
Dog 9049 4 4 
Dog 9062 3 4 
Mean 3.6 3.2 
SD 0.547 0.836 
SEM 0.244 0.374 
Group  
Fish oil + E 
Dog 9005 3 3 
Dog 9038 4 4 
Dog 9050 3 3 
Dog 9058 2 3 
Dog 9061 4 3 
Mean 3.2 3.2 
SD 0.836 0.447 
SEM 0.374 0.2 
(% 
Proliferation) Week 0 Week 12 
Group  
Sunflower oil 
Dog 9002 19.1 11.9 
Dog 9028 26.7 20.6 
Dog 9040 40.1 11.8 
Dog 9057 15.3 16.8 
Dog 9060 38.3 26.5 
Mean 27.9 17.52 
SD 11.12025 6.223906 
SEM 4.973128 2.783415 
Group  
Fish oil 
Dog 9003 37.7 32.1 
Dog 9031 44.7 26 
Dog 9039 50.7 7.2 
Dog 9049 41.1 25.5 
Dog 9062 49.9 39.2 
Mean 44.82 26 
SD 5.58856 11.88634 
SEM 2.49928 5.315731 
Group  
Fish oil + E 
Dog 9005 12.9 19.9 
Dog 9038 35.1 42.2 
Dog 9050 50.8 36.7 
Dog 9058 27.2 29.2 
Dog 9061 48.6 9.3 
Mean 34.92 27.46 
SD 15.68302 13.15876 











APPENDIX XI: PERCENT IL-2 RECEPTOR EXPRESSION  
BY FLOW CYTOMETRY 
 
(%) Week 0 Week 12 
Group  
Sunflower oil 
Dog 9002 42.17 50.61 
Dog 9028 64.56 52.47 
Dog 9040 76.04 28.3 
Dog 9057 45.79 51.54 
Dog 9060 75.44 78.59 





Dog 9003 76.4 74.07 
Dog 9031 76.31 65.51 
Dog 9039 84.96 44.28 
Dog 9049 69.7 66.35 
Dog 9062 82.91 78.61 




Fish oil + E 
Dog 9005 53.97 73.91 
Dog 9038 84.45 70.54 
Dog 9050 89.77 47.03 
Dog 9058 68.87 59.56 
Dog 9061 74.83 29.76 















APPENDIX XII: MONONUCLEAR CELL CULTURE  
PGE2 CONCENTRATION 
 
(pg/mL) Week 0 Week 12 
Group  
Sunflower oil 
Dog 9028 8371.3 1962.5 
Dog 9040 7656.6 5136.25 






Dog 9031 5767.4 1697.4 
Dog 9039 5158 2244.4 





Fish oil + E 
Dog 9005 10396.8 1573 
Dog 9038 17954.9 3325.2 
Dog 9058 6866.9 1968.4 
Dog 9061 2770.6 1220.6 




















APPENDIX XIII: RECTAL TEMPERATURE AFTER  
INTRAVENOUS LPS INJECTIOIN 
 
(oF) Baseline 0.5 Hr 1 Hr 1.5 Hr 2 Hr 3 Hr 4 Hr 5 Hr 6 Hr 
Group  
Sunflower oil 
Dog 9002 101.6 101.2 100.8 100.5 101.2 101.3 100.9 101.3 100.8 
Dog 9028 101.6 101.8 101.8 101.5 102.1 102.1 101.5 101.3 101.2 
Dog 9040 101.8 101.7 100.2 100.9 101 101.4 100.8 100.7 100.7 
Dog 9057 101.8 101.4 101.8 102 102 101.1 101.8 100.7 100.9 
Dog 9060 100.8 102.1 102.3 101.7 101.7 101.6 101.5 101.4 100.8 
Group  
Fish oil 
Dog 9003 102.2 101.6 101.6 101.8 101.5 102.7 102.2 102.2 101.9 
Dog 9031 101.4 102.8 102.9 102.6 102.2 102.1 101.8 101.3 101 
Dog 9039 101.6 101.3 101.7 101.6 101.4 100.5 100.3 100.1 100.4 
Dog 9049 102 101.4 101.3 102 101.6 100.9 101.4 101.7 101 
Dog 9062 102.4 101.7 102 102.2 101.9 101.7 101.6 100.9 100.3 
Group  
Fish oil + E 
Dog 9005 102 102.1 102.1 101.8 101.9 101.7 101.8 101.7 101.1 
Dog 9038 101.2 102.1 102.2 102.1 101.2 100.8 101.2 100.8 101 
Dog 9050 102 101.7 101.9 101.7 102 102.1 101.7 101.1 100.8 
Dog 9058 101.6 101.6 101.5 101.4 101.3 100.8 101.1 100.9 100.9 





















APPENDIX XIV: SERUM IL-1 ACTIVITY AFTER 




(U/mL) 9002 9028 9040 9057 9060 Mean SD SEM 
Baseline 578.66 41.33 875.86 1014.29 1758.86 853.8 628.7263 281.1749
0.5 Hr 925.33 0 775.86 964.29 2124.57 958.01 760.4162 340.0685
1 Hr 2078.66 1796.88 500 550 610.29 1107.166 765.7474 342.4526
1.5 Hr 1392 503.55 337.93 657.14 216 621.324 461.978 206.6028
2 Hr 1185.33 228 151.72 971.43 1393.14 785.924 564.8325 252.6008
3 Hr 1165.33 539.11 382.76 921.43 2038.86 1009.498 653.0105 292.0352
4 Hr 1985.33 1081.33 1486.21 1885.71 2153.14 1718.344 432.4389 193.3925
6 Hr 1632 1076.88 1648.27 2321.43 2907.43 1917.202 707.7707 316.5247
Group  
Fish oil 
 9003 9031 9039 9049 9062 Mean SD SEM 
Baseline 138.66 1220.75 0 265.5 741.71 473.324 502.4697 224.7113
0.5 Hr 538.66 0 0 0 827.43 273.218 387.7998 173.4293
1 Hr 1705.33 0 0 0 1616 664.266 910.1318 407.0233
1.5 Hr 1238.66 737.73 0 0 998.86 595.05 571.363 255.5213
2 Hr 452 164.15 0 0 370.29 197.288 208.4173 93.20706
3 Hr 485.33 0 93.1 0 958.85 307.456 415.6201 185.8709
4 Hr 1045.33 1333.96 131 31 1421.71 792.6 665.2954 297.5291
6 Hr 1038.66 1541.5 886.2 427.58  973.785 459.1731 229.5865
Group  
Fish oil + E 
 9005 9038 9050 9058 9061 Mean SD SEM 
Baseline 605.33 152.44 226.66 0 187.43 234.372 224.4526 100.3783
0.5 Hr 865.33 165.77 1469.8 0 250.29 550.238 609.3898 272.5274
1 Hr 1378.66 596.88 803.14 0 438.86 643.508 505.9863 226.2839
1.5 Hr 525.33 165.77 2536.47 0 587.43 763 1021.195 456.6925
2 Hr 465.33 41.33 265.88 0 113.14 177.136 190.294 85.10206
3 Hr 358.66 468 1661.96 0 884.57 674.638 635.7189 284.3021
4 Hr 912 623.55 1383.53 591.37 1450.29 992.148 408.0396 182.4808












APPENDIX XV: MONONUCLEAR CELL CUTLURE  





(U/mL) Week 0 Week 12 
Group 
Sunflower oil 
Dog 9028 2.35 3.53 
Dog 9040 2.2 3.45 
Dog 9057 2.03 3.52 
Mean 2.193333 3.5 
SD 0.160104 0.043589 
SEM 0.092436 0.025166 
Group 
Fish oil 
Dog 9031 1.82 2.99 
Dog 9039 2.17 2.06 
Dog 9049 2.14 3.48 
Mean 2.043333 2.843333 
SD 0.193993 0.721272 
SEM 0.112002 0.416427 
Group 
Fish oil + E 
Dog 9005 2.59 3.49 
Dog 9038 2.15 2.94 
Dog 9058 3.45 3.57 
Dog 9061 2.31 3.59 
Mean 2.625 3.3975 
SD 0.579281 0.308045 
SEM 0.289641 0.154022 
IL-1 
(U/mL) Week 0 Week 12
Group 
Sunflower oil 
Dog 9028 680.44 0 
Dog 9040 740.15 541.46 






Dog 9031 773.09 276.59 
Dog 9039 721.62 369.3 





Fish oil + E 
Dog 9005 742.21 0 
Dog 9038 513.68 284.16 
Dog 9058 563.09  
Dog 9061 694.85 284.16 
Mean 628.4575 189.44 
SD 107.6946 164.0599
















APPENDIX XVI: SERUM IL-6 ACTIVITY AFTER 




(U/mL) 9002 9028 9040 9057 9060 Mean SD SEM 
Baseline 0 0.23 0 1.03 0.03 0.258 0.44212 0.197722
0.5 Hr 0 0.18 7.6 0.43 0 1.642 3.335284 1.491584
1 Hr 2.24 6 0.07 2.86 4.06 3.046 2.196311 0.98222 
1.5 Hr 7.57 9.61 12.5 8.43 8.54 9.33 1.914354 0.856125
2 Hr 5.65 9.13 10.8 9.34 7.77 8.538 1.939116 0.867199
3 Hr 6.95 7.92 9.99 5.33 1.07 6.252 3.352062 1.499088
4 Hr 6.35 7.81 6.16 1.87 0 4.438 3.327232 1.487983
6 Hr 0 0 0 0.98 0 0.196 0.438269 0.196 
Group 
Fish oil 
 9003 9031 9039 9049 9062 Mean SD SEM 
Baseline 0 0 0 0 0 0 0 0 
0.5 Hr 0 0 0 0 0 0 0 0 
1 Hr 1.53 6 0.094 0 1.32 1.7888 2.454237 1.097568
1.5 Hr 5.13 5.16 0.745 1.67 8.4 4.221 3.072549 1.374086
2 Hr 5.68 6.19 5.09 2.13 8.22 5.462 2.203672 0.985512
3 Hr 6.2 5.49 1.125 0 7.94 4.151 3.418162 1.528648
4 Hr 3.79 0 0 0 0.21 0.8 1.673932 0.748605
6 Hr 0 0 0 0 0 0 0 0 
Group 
Fish oil + E 
 9005 9038 9050 9058 9061 Mean SD SEM 
Baseline 0 0 0.27 0 0 0.054 0.120748 0.054 
0.5 Hr 0 0.04 0.2 0 0 0.048 0.086718 0.038781
1 Hr 1.36 2.5 3.28 0.08 0.38 1.52 1.365357 0.610606
1.5 Hr 6.45 6.73 9.63 5.55 4.62 6.596 1.887003 0.843893
2 Hr 7.8 8.61 10.1 5.36 4.39 7.252 2.346608 1.049435
3 Hr 6.76 7.03 10.2 0 0.42 4.882 4.476753 2.002065
4 Hr 2.28 4.81 8.23 0 0 3.064 3.50453 1.567273












APPENDIX XVII: SERUM TNF-α ACTIVITY AFTER 




(U/mL) 9002 9028 9040 9057 9060 Mean SD SEM 
Baseline 8.2 1.6 0 0 0 1.96 3.556403 1.590472
0.5 Hr 11.4 11.1 2.1 0 9.9 6.9 5.420793 2.424252
1 Hr 26.8 10.9 0 1.77 11.9 10.274 10.65384 4.764544
1.5 Hr 18.1 7.7 0 0 0.5 5.26 7.886888 3.527123
2 Hr 10.9 5.7 0 0 1.7 3.66 4.669368 2.088205
3 Hr 0 0 0 0 0 0 0 0 
4 Hr 0.7 0 0 0 0 0.14 0.31305 0.14 
6 Hr 0 0 0 0 0 0 0 0 
Group 
Fish oil 
 9003 9031 9039 9049 9062 Mean SD SEM 
Baseline 0 0 1.8 0 0 0.36 0.804984 0.36 
0.5 Hr 0 9.4 8.8 14.2 0 6.48 6.274711 2.806136
1 Hr 24.4 7.9 6.3 9.6 7.9 11.22 7.459692 3.336076
1.5 Hr 14.5 0 3.2 6.2 2.2 5.22 5.646415 2.525153
2 Hr 6.8 0 2.7 1.1 0 2.12 2.840246 1.270197
3 Hr 0 0 0 0 0 0 0 0 
4 Hr 0 0 0 1.6 0 0.32 0.715542 0.32 
6 Hr 0 0 0 0 0 0 0 0 
Group 
Fish oil + E 
 9005 9038 9050 9058 9061 Mean SD SEM 
Baseline 0 0 2.2 1.8 0 0.8 1.104536 0.493964
0.5 Hr 6.9 0 7.9 5.9 2.2 4.58 3.346192 1.496462
1 Hr 21.7 10.3 20.5 9.5 0 12.4 8.925805 3.991741
1.5 Hr 16 2.8 17.9 12.2 0 9.78 7.98198 3.56965 
2 Hr 16.2 4.4 5.1 0 0 5.14 6.62782 2.964051
3 Hr 0 0 0 0 0 0 0 0 
4 Hr 0 0 0 0 0 0 0 0 












APPENDIX XVIII: SERUM PAF CONCENTRATION AFTER  




(pg/sample) 9002 9028 9040 9057 9060 Means SD SEM 
Baseline 136.3 282.2 351.6 495.2 320.9 317.24 129.258 57.806 
0.5 Hr 742.4 610.9 1008.4 637.9 760.9 752.1 157.194 70.299 
1 Hr 425.4 277.8 422.5 471 679.4 455.22 144.864 64.785 
1.5 Hr 806.1 734.9 1149.5 1354.8 1504.8 1110.02 335.562 150.068 
2 Hr 459 287.4 1280 616.9 763.8 681.42 378.803 169.406 
3 Hr 160.4 186.4 338.3 333.2 436.4 290.94 115.278 51.554 
4 Hr 221.8 198.5 319.7 369.7 309.3 283.8 71.480 31.967 
6 Hr 228.6 298.9 352.6 317.4 438.7 327.24 76.967 34.4211 
Group 
Fish oil 
 9003 9031 9039 9049 9062 Means SD SEM 
Baseline 142.6 248.1 238.2 206.3 562.5 279.54 163.462 73.102 
0.5 Hr 494.2 462.3 804.1 659.4 557.8 595.56 138.764 62.057 
1 Hr 204.9 287.7 406 295.1 602.8 359.3 153.753 68.760 
1.5 Hr 661.6 928.3 889.2 1177.46 1493.4 1029.992 317.163 141.839 
2 Hr  720.8 1004.6 1022.2  915.866 169.161 97.665 
3 Hr 223 244.7 332.1 516.8 465.9 356.5 130.940 58.558 
4 Hr 240.4 305.3 311.5 299.9 247.9 281 33.992 15.201 
6 Hr 185.2 351.8 403.2 298.5 327.6 313.26 81.236 36.330 
Group 
Fish oil + E 
 9005 9038 9050 9058 9061 Means SD SEM 
Baseline 564.3 239.2 569.9 562 288.9 444.86 166.013 74.243 
0.5 Hr 724.6 510.6 1023.3 615.9 589.1 692.7 200.065 89.472 
1 Hr 363.9  543.2 865.8 757.1 632.5 223.662 111.831 
1.5 Hr 948.6 1012.7 1426.8 1119.6 1005.7 1102.68 191.430 85.610 
2 Hr  706.2 506.4  502.5 571.7 116.496 67.259 
3 Hr 336.5 239.4 309.9 407.9 354.1 329.56 61.852 27.661 
4 Hr 299.7 215.7 264.5 586.6 278.4 328.98 147.286 65.868 












APENDIX XIX: MONONUCLEAR CELL CULTURE  
PAF CONCENTRATION 
 
(pg/mL) Week 0 Week 12
Group 
Sunflower oil 
Dog 9028 94.8 117.1 
Dog 9040 154.8 221.7 
Dog 9057 101.5 117.2 





Dog 9031 125.3 92.8 
Dog 9039 179.7 137.9 
Dog 9049 148.1 140.1 




Fish oil + E 
Dog 9005 174.7 106.4 
Dog 9038 230.2 148.8 
Dog 9058 81.9 194.4 
Dog 9061 140.9 87.8 
Mean 156.925 134.35 



















APPENDIX XX: SERUM PGE2 CONCENTRATION AFTER 




(pg/mL) 9002 9028 9040 9057 9060 Mean SD SEM 
Baseline 165.5 135.7 183.2 143.8 116.6 148.96 25.959 11.609 
0.5 Hr 278.9 318.4 1022.1 244.7 216.7 416.16 340.860 152.437 
1 Hr 620.8 354.2 377 221.4 144.4 343.56 182.127 81.449 
1.5 Hr 419.1 297.5 378.5 246.5 171.3 302.58 99.681 44.579 
2 Hr 382.9 186.3 370 211.4 151.1 260.34 108.232 48.402 
3 Hr 315.7 93.3 195 168.9 161.1 186.8 81.249 36.335 
4 Hr 179.6 54.1 174.3 113.1 133.5 130.92 51.178 22.887 
5 Hr 125.8 50.2 160.4 132.5 113.8 116.54 40.843 18.265 
6 Hr 127.7 80.7 124.8 121.9 95.1 110.04 20.942 9.365 
Group 
Fish oil 
 9003 9031 9039 9049 9062 Mean SD SEM 
Baseline 118.2 86.2 129.4 97 92.1 104.58 18.388 8.223 
0.5 Hr 171.9 218.7 157.2 97.8 104.4 150 50.1381 22.422 
1 Hr 308 316.9 143.2 108.3 126.6 200.6 102.896 46.016 
1.5 Hr 179.6 158.5 170.5 116.4 198.3 164.66 30.642 13.703 
2 Hr 137.1 116.2 139.8 134.8 125.5 130.68 9.71941 4.346 
3 Hr 76.1 84.4 191.3 120.1 122.9 118.96 45.500 20.348 
4 Hr 55.6 65.5 143.7 118.7 94.8 95.66 36.585 16.361 
5 Hr 65.2 41.5 124.1 105.9 103.5 88.04 33.711 15.076 
6 Hr 42.9 33.5 113.5 102.5 59.2 70.32 35.816 16.017 
Group 
Fish oil + E 
 9005 9038 9050 9058 9061 Mean SD SEM 
Baseline 75.3 101.4 112.4 72.8 100.1 92.4 17.441 7.800 
0.5 Hr 119.6 328.7 128.9 134.9 120.1 166.44 90.930 40.665 
1 Hr 235.3 218 210.7 123 121.5 181.7 55.003 24.598 
1.5 Hr 305.3 293.6 199 122.3 106.7 205.38 92.800 41.501 
2 Hr 116.9 158.3 145.5 128 89 127.54 26.774 11.973 
3 Hr 55.4 121.1 150.5 107.3 81 103.06 36.578 16.358 
4 Hr 53.6 119.3 100 105.2 107.5 97.12 25.334 11.329 
5 Hr 47.6 108 93.7 124 122.1 80.34 31.263 13.981 
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